false Q2 0001719489 --12-31 P7Y P4M P4M P6Y true 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 P20D P30D 0.0310 0.0310 0.0290 0.0390 0.0180 0.0260 0.0165 0.0170 0.0125 0.0195 0.0095 0.0150 0.0200 0.0300 0.0050 0.0050 0.0050 0001719489 2021-01-01 2021-06-30 xbrli:shares 0001719489 2021-08-03 0001719489 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001719489 us-gaap:WarrantMember 2021-01-01 2021-06-30 iso4217:USD 0001719489 2021-06-30 0001719489 2020-12-31 iso4217:USD xbrli:shares 0001719489 2021-04-01 2021-06-30 0001719489 2020-04-01 2020-06-30 0001719489 2020-01-01 2020-06-30 0001719489 us-gaap:CommonStockMember 2021-03-31 0001719489 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001719489 us-gaap:TreasuryStockMember 2021-03-31 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2021-03-31 0001719489 us-gaap:RetainedEarningsMember 2021-03-31 0001719489 2021-03-31 0001719489 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001719489 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001719489 us-gaap:CommonStockMember klr:MGageMember 2021-04-01 2021-06-30 0001719489 us-gaap:AdditionalPaidInCapitalMember klr:MGageMember 2021-04-01 2021-06-30 0001719489 klr:MGageMember 2021-04-01 2021-06-30 0001719489 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2021-04-01 2021-06-30 0001719489 us-gaap:CommonStockMember 2021-06-30 0001719489 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001719489 us-gaap:TreasuryStockMember 2021-06-30 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2021-06-30 0001719489 us-gaap:RetainedEarningsMember 2021-06-30 0001719489 us-gaap:CommonStockMember 2020-03-31 0001719489 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001719489 us-gaap:TreasuryStockMember 2020-03-31 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-03-31 0001719489 us-gaap:RetainedEarningsMember 2020-03-31 0001719489 2020-03-31 0001719489 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001719489 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001719489 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0001719489 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-04-01 2020-06-30 0001719489 us-gaap:CommonStockMember 2020-06-30 0001719489 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001719489 us-gaap:TreasuryStockMember 2020-06-30 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-06-30 0001719489 us-gaap:RetainedEarningsMember 2020-06-30 0001719489 2020-06-30 0001719489 us-gaap:CommonStockMember 2020-12-31 0001719489 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001719489 us-gaap:TreasuryStockMember 2020-12-31 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-12-31 0001719489 us-gaap:RetainedEarningsMember 2020-12-31 0001719489 us-gaap:CommonStockMember klr:CowenInvestmentsMember 2021-01-01 2021-06-30 0001719489 us-gaap:AdditionalPaidInCapitalMember klr:CowenInvestmentsMember 2021-01-01 2021-06-30 0001719489 klr:CowenInvestmentsMember 2021-01-01 2021-06-30 0001719489 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001719489 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001719489 us-gaap:CommonStockMember klr:MGageMember 2021-01-01 2021-06-30 0001719489 us-gaap:AdditionalPaidInCapitalMember klr:MGageMember 2021-01-01 2021-06-30 0001719489 klr:MGageMember 2021-01-01 2021-06-30 0001719489 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2021-01-01 2021-06-30 0001719489 us-gaap:CommonStockMember 2019-12-31 0001719489 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-12-31 0001719489 us-gaap:RetainedEarningsMember 2019-12-31 0001719489 2019-12-31 0001719489 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001719489 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0001719489 us-gaap:TreasuryStockMember 2020-01-01 2020-06-30 0001719489 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0001719489 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-01 2020-06-30 0001719489 klr:MGageMember 2021-06-01 0001719489 klr:MGageMember 2021-05-31 2021-06-01 0001719489 klr:CowenInvestmentsLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMember 2020-05-01 2020-05-01 0001719489 klr:CowenInvestmentsLimitedLiabilityCompanyMember 2020-05-01 2020-05-01 0001719489 klr:ChardanCapitalMarketsLimitedLiabilityCompanyMember 2020-05-01 2020-05-01 xbrli:pure 0001719489 klr:SponsorsMember 2021-03-16 2021-03-16 0001719489 klr:NorthlandSecuritiesIncMember 2020-03-06 2020-03-06 0001719489 klr:MGageEuropeLtdMember 2021-01-01 2021-06-30 0001719489 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0001719489 klr:MGageMember 2021-02-18 2021-02-18 0001719489 klr:PIPESubscriptionAgreementsMember 2021-02-18 2021-02-18 0001719489 klr:PIPESubscriptionAgreementsMember 2021-02-18 0001719489 2019-11-25 2019-11-25 0001719489 2019-11-25 0001719489 2021-02-18 2021-02-18 0001719489 klr:PIPESubscriptionAgreementsMember us-gaap:PrivatePlacementMember 2021-02-18 0001719489 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-04-01 2021-06-30 0001719489 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-04-01 2020-06-30 0001719489 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-06-30 0001719489 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-06-30 klr:Customer 0001719489 klr:CustomerOneMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-04-01 2020-06-30 0001719489 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2021-01-01 2021-06-30 0001719489 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0001719489 klr:CustomerOneMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2021-01-01 2021-06-30 0001719489 klr:CustomerOneMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0001719489 klr:PIPESubscriptionAgreementsMember klr:MGageMember 2021-02-18 2021-02-18 0001719489 klr:PIPESubscriptionAgreementsMember klr:MGageMember 2021-02-18 0001719489 klr:MGageMember 2021-02-18 0001719489 us-gaap:CustomerRelationshipsMember srt:MinimumMember klr:MGageMember 2021-02-18 2021-02-18 0001719489 us-gaap:CustomerRelationshipsMember srt:MaximumMember klr:MGageMember 2021-02-18 2021-02-18 0001719489 us-gaap:DevelopedTechnologyRightsMember klr:MGageMember 2021-02-18 2021-02-18 0001719489 us-gaap:TradeNamesMember klr:MGageMember 2021-02-18 2021-02-18 0001719489 us-gaap:GeneralAndAdministrativeExpenseMember klr:MGageMember 2021-01-01 2021-06-30 0001719489 srt:ProFormaMember klr:MGageMember 2021-04-01 2021-06-30 0001719489 srt:ProFormaMember klr:MGageMember 2021-01-01 2021-06-30 0001719489 srt:ProFormaMember klr:MGageMember 2020-04-01 2020-06-30 0001719489 srt:ProFormaMember klr:MGageMember 2020-01-01 2020-06-30 0001719489 srt:ProFormaMember klr:MGageMember 2021-01-02 2021-06-01 0001719489 srt:ProFormaMember klr:MGageMember 2021-04-01 2021-06-01 0001719489 klr:MGageMember 2020-04-01 2020-06-30 0001719489 klr:MGageMember 2020-01-01 2020-06-30 0001719489 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MutualFundMember 2021-06-30 0001719489 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MutualFundMember 2021-06-30 0001719489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2021-06-30 0001719489 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2021-06-30 0001719489 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001719489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001719489 us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001719489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember 2021-06-30 0001719489 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember 2021-06-30 0001719489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember klr:WarrantLiabilityMember 2021-06-30 0001719489 us-gaap:FairValueMeasurementsRecurringMember klr:WarrantLiabilityMember 2021-06-30 0001719489 srt:MinimumMember 2021-01-01 2021-06-30 0001719489 srt:MaximumMember 2021-01-01 2021-06-30 0001719489 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MutualFundMember 2020-12-31 0001719489 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MutualFundMember 2020-12-31 0001719489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2020-12-31 0001719489 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2020-12-31 0001719489 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001719489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001719489 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001719489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember 2020-12-31 0001719489 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember 2020-12-31 0001719489 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember klr:ForwardSharePurchaseAgreementMember 2020-12-31 0001719489 us-gaap:FairValueMeasurementsRecurringMember klr:ForwardSharePurchaseAgreementMember 2020-12-31 0001719489 srt:MinimumMember 2020-01-01 2020-12-31 0001719489 srt:MaximumMember 2020-01-01 2020-12-31 0001719489 us-gaap:MutualFundMember 2021-06-30 0001719489 us-gaap:CertificatesOfDepositMember 2021-06-30 0001719489 us-gaap:MutualFundMember 2020-12-31 0001719489 us-gaap:CertificatesOfDepositMember 2020-12-31 0001719489 2020-01-01 2020-12-31 0001719489 klr:PreferenceSharesLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-06-30 0001719489 klr:PreferenceSharesLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-06-30 0001719489 klr:PreferenceSharesLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-06-30 0001719489 klr:PreferenceSharesLiabilityMember us-gaap:FairValueInputsLevel3Member klr:FinancialIncomeExpenseNetMember 2020-01-01 2020-06-30 0001719489 klr:PreferenceSharesLiabilityMember us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-06-30 iso4217:EUR 0001719489 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2021-06-30 0001719489 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2020-12-31 0001719489 us-gaap:InterestRateSwapMember klr:FinancialIncomeExpenseMember 2021-04-01 2021-06-30 0001719489 us-gaap:InterestRateSwapMember klr:FinancialIncomeExpenseMember 2020-04-01 2020-06-30 0001719489 us-gaap:InterestRateSwapMember klr:FinancialIncomeExpenseMember 2021-01-01 2021-06-30 0001719489 us-gaap:InterestRateSwapMember klr:FinancialIncomeExpenseMember 2020-01-01 2020-06-30 0001719489 us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NondesignatedMember 2021-06-30 0001719489 us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NondesignatedMember 2020-12-31 0001719489 us-gaap:NondesignatedMember 2021-06-30 0001719489 us-gaap:NondesignatedMember 2020-12-31 0001719489 us-gaap:DevelopedTechnologyRightsMember 2021-06-30 0001719489 us-gaap:CustomerRelationshipsMember 2021-06-30 0001719489 us-gaap:TradeNamesMember 2021-06-30 0001719489 us-gaap:PatentsMember 2021-06-30 0001719489 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0001719489 us-gaap:CustomerRelationshipsMember 2020-12-31 0001719489 us-gaap:PatentsMember 2020-12-31 0001719489 klr:UnicreditSPALineATrancheOneMember 2021-06-30 0001719489 klr:UnicreditSPALineATrancheOneMember 2020-12-31 0001719489 klr:UnicreditSPALineATrancheTwoMember 2021-06-30 0001719489 klr:UnicreditSPALineATrancheTwoMember 2020-12-31 0001719489 klr:UnicreditSPALineBMember 2021-06-30 0001719489 klr:UnicreditSPALineBMember 2020-12-31 0001719489 klr:UnicreditSPALineCMember 2021-06-30 0001719489 klr:UnicreditSPALineCMember 2020-12-31 0001719489 klr:IntesaSanPaoloSPALineOneMember 2021-06-30 0001719489 klr:IntesaSanPaoloSPALineOneMember 2020-12-31 0001719489 klr:IntesaSanPaoloSPALineTwoMember 2021-06-30 0001719489 klr:IntesaSanPaoloSPALineTwoMember 2020-12-31 0001719489 klr:IntesaSanPaoloSPALineThreeMember 2021-06-30 0001719489 klr:IntesaSanPaoloSPALineThreeMember 2020-12-31 0001719489 klr:IntesaSanPaoloSPALineFourMember 2021-06-30 0001719489 klr:IntesaSanPaoloSPALineFourMember 2020-12-31 0001719489 klr:UBIBancaSPALineOneMember 2021-06-30 0001719489 klr:UBIBancaSPALineOneMember 2020-12-31 0001719489 klr:UBIBancaSPALineTwoMember 2021-06-30 0001719489 klr:UBIBancaSPALineTwoMember 2020-12-31 0001719489 klr:MonteDeiPaschiDiSienaSPALine1Member 2021-06-30 0001719489 klr:MonteDeiPaschiDiSienaSPALine1Member 2020-12-31 0001719489 klr:MonteDeiPaschiDiSienaSPALine2Member 2021-06-30 0001719489 klr:MonteDeiPaschiDiSienaSPALine2Member 2020-12-31 0001719489 klr:BancoBPMSPALineOneMember 2021-06-30 0001719489 klr:BancoBPMSPALineOneMember 2020-12-31 0001719489 klr:BancoBPMSPALineThreeMember 2021-06-30 0001719489 klr:BancoBPMSPALineThreeMember 2020-12-31 0001719489 klr:SimestOneMember 2021-06-30 0001719489 klr:SimestOneMember 2020-12-31 0001719489 klr:SimestTwoMember 2021-06-30 0001719489 klr:SimestTwoMember 2020-12-31 0001719489 klr:SimestThreeMember 2021-06-30 0001719489 klr:SimestThreeMember 2020-12-31 0001719489 klr:UnicreditSPALineATrancheOneMember 2021-01-01 2021-06-30 0001719489 klr:UnicreditSPALineATrancheTwoMember 2021-01-01 2021-06-30 0001719489 klr:UnicreditSPALineBMember 2021-01-01 2021-06-30 0001719489 klr:UnicreditSPALineCMember 2021-01-01 2021-06-30 0001719489 klr:IntesaSanPaoloSPALineOneMember 2021-01-01 2021-06-30 0001719489 klr:IntesaSanPaoloSPALineTwoMember 2021-01-01 2021-06-30 0001719489 klr:IntesaSanPaoloSPALineThreeMember 2021-01-01 2021-06-30 0001719489 klr:IntesaSanPaoloSPALineFourMember 2021-01-01 2021-06-30 0001719489 klr:UBIBancaSPALineOneMember 2021-01-01 2021-06-30 0001719489 klr:UBIBancaSPALineTwoMember 2021-01-01 2021-06-30 0001719489 klr:MonteDeiPaschiDiSienaSPALine1Member 2021-01-01 2021-06-30 0001719489 klr:MonteDeiPaschiDiSienaSPALine2Member 2021-01-01 2021-06-30 0001719489 klr:BancoBPMSPALineOneMember 2021-01-01 2021-06-30 0001719489 klr:BancoBPMSPALineThreeMember 2021-01-01 2021-06-30 0001719489 klr:SimestOneMember 2021-01-01 2021-06-30 0001719489 klr:SimestTwoMember 2021-01-01 2021-06-30 0001719489 klr:SimestThreeMember 2021-01-01 2021-06-30 0001719489 klr:IntesaSanPaoloSPAMember klr:KaleyraIncorporationMember klr:UnsecuredLoanAgreementMember 2021-01-01 2021-06-30 0001719489 klr:IntesaSanPaoloSPAMember klr:KaleyraIncorporationMember us-gaap:SubsequentEventMember klr:UnsecuredLoanAgreementMember 2021-08-02 2021-08-03 0001719489 klr:GeneralUnsecuredLoanAgreementMember klr:SimestSPAMember klr:KaleyraIncorporationMember 2021-04-15 0001719489 klr:GeneralUnsecuredLoanAgreementMember klr:FundForIntegratedPromotionMember klr:KaleyraIncorporationMember 2021-04-15 0001719489 klr:GeneralUnsecuredLoanAgreementMember klr:Fund39481Member klr:KaleyraIncorporationMember 2021-04-15 0001719489 klr:GeneralUnsecuredLoanAgreementMember klr:KaleyraIncorporationMember 2021-04-15 2021-04-15 0001719489 klr:GeneralUnsecuredLoanAgreementMember klr:KaleyraIncorporationMember 2021-01-01 2021-06-30 0001719489 klr:ForwardSharePurchaseAgreementMember 2021-06-30 0001719489 klr:ForwardSharePurchaseAgreementMember klr:ThirdYakiraAmendmentMember klr:OpenMarketMember 2021-01-25 2021-03-02 0001719489 klr:ForwardSharePurchaseAgreementMember klr:OpenMarketMember 2020-01-01 2020-12-31 0001719489 klr:ForwardSharePurchaseAgreementMember klr:ThirdYakiraAmendmentMember srt:MinimumMember klr:OpenMarketMember 2021-03-02 0001719489 klr:ForwardSharePurchaseAgreementMember klr:ThirdYakiraAmendmentMember klr:OpenMarketMember 2021-03-29 2021-03-29 0001719489 klr:ForwardSharePurchaseAgreementMember klr:ThirdYakiraAmendmentMember klr:OpenMarketMember 2021-03-29 0001719489 klr:NomuraGlobalFinancialProductsMember klr:KaleyraIncorporationMember klr:ForwardSharePurchaseAgreementMember 2021-02-25 2021-02-25 0001719489 klr:NomuraGlobalFinancialProductsMember klr:KaleyraIncorporationMember klr:ForwardSharePurchaseAgreementMember 2021-02-25 0001719489 klr:EsseEffeSPAMember 2019-11-25 2019-11-25 0001719489 klr:MayaInvestmentsLimitedMember 2019-11-25 2019-11-25 0001719489 klr:NonConvertibleUnsecuredPromissoryNotesMember 2021-06-30 0001719489 klr:EsseEffeSPAMember klr:ConvertibleNotesMember 2021-06-30 0001719489 klr:MayaInvestmentsLimitedMember klr:ConvertibleNotesMember 2021-06-30 0001719489 klr:ConvertibleUnsecuredPromissoryNotesMember 2021-01-01 2021-06-30 0001719489 klr:EsseEffeSPAMember klr:ConvertibleUnsecuredPromissoryNotesMember 2021-06-30 0001719489 klr:MayaInvestmentsLimitedMember klr:ConvertibleUnsecuredPromissoryNotesMember 2021-06-30 0001719489 klr:ConvertibleUnsecuredPromissoryNotesMember 2021-06-30 0001719489 klr:MayaInvestmentsLimitedMember klr:ConvertibleUnsecuredPromissoryNotesMember 2021-06-02 0001719489 klr:MayaInvestmentsLimitedMember klr:ConvertibleUnsecuredPromissoryNotesMember 2021-05-31 2021-06-02 0001719489 klr:EsseEffeSPAMember 2021-06-02 0001719489 klr:EsseEffeSPAMember 2021-05-31 2021-06-02 0001719489 klr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMember 2020-04-16 2020-04-16 0001719489 klr:ResaleRegistrationStatementMember klr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMember 2020-04-16 0001719489 klr:ResaleRegistrationStatementMember klr:ConvertibleNotesMember klr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMember 2020-04-16 0001719489 klr:ResaleRegistrationStatementMember klr:ConvertibleNotesMember klr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMember 2020-04-16 2020-04-16 0001719489 klr:ResaleRegistrationStatementMember klr:CowenAndCompanyLimitedLiabilityCompanyAndChardanCapitalMarketsLimitedLiabilityCompanyMember 2020-04-16 2020-04-16 utr:D 0001719489 klr:CowenInvestmentsAndChardanMember 2020-05-01 0001719489 klr:CowenInvestmentsMember 2020-05-01 0001719489 klr:ChardanMember 2020-05-01 0001719489 klr:ChardanMember 2020-05-01 2020-05-01 0001719489 klr:CowenInvestmentsMember 2020-05-01 2020-05-01 0001719489 2020-05-01 0001719489 klr:CowenInvestmentsMember 2020-12-31 0001719489 klr:ChardanMember 2020-12-31 0001719489 us-gaap:OtherCurrentLiabilitiesMember klr:CowenInvestmentsMember 2020-12-31 0001719489 us-gaap:OtherCurrentLiabilitiesMember klr:ChardanMember 2020-12-31 0001719489 klr:CowenInvestmentsMember 2021-02-04 2021-02-04 0001719489 klr:CowenInvestmentsMember 2021-02-04 0001719489 klr:ChardanMember 2021-06-30 0001719489 us-gaap:OtherCurrentLiabilitiesMember klr:ChardanMember 2021-06-30 0001719489 klr:ConvertibleNotesMember 2021-06-01 0001719489 klr:ConvertibleNotesMember klr:WilmingtonTrustNationalAssociationMember 2021-06-30 0001719489 klr:ConvertibleNotesMember 2021-06-30 0001719489 klr:ConvertibleNotesMember 2021-01-01 2021-06-30 0001719489 klr:ConvertibleNotesMember klr:FirstAnniversaryMember 2021-01-01 2021-06-30 0001719489 klr:ConvertibleNotesMember klr:SecondAnniversaryMember 2021-01-01 2021-06-30 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001719489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0001719489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-03-31 0001719489 2021-01-01 2021-03-31 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0001719489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-03-31 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2021-04-01 2021-06-30 0001719489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-04-01 2021-06-30 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0001719489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-06-30 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001719489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0001719489 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0001719489 2020-01-01 2020-03-31 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-01 2020-06-30 0001719489 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0001719489 klr:SolutionsInfiniPurchaseAgreementMember 2021-06-30 0001719489 klr:SolutionsInfiniPurchaseAgreementMember 2020-12-31 0001719489 klr:COVID19Member us-gaap:PreferredStockMember klr:SolutionsInfiniMember klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember 2020-12-31 0001719489 klr:SolutionsInfiniMember klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember 2020-03-09 2020-03-09 0001719489 us-gaap:PreferredStockMember klr:SolutionsInfiniMember klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember 2020-08-31 0001719489 us-gaap:PreferredStockMember klr:SolutionsInfiniMember klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember 2020-11-30 klr:Installment 0001719489 us-gaap:PreferredStockMember klr:SolutionsInfiniMember klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember 2020-08-30 2020-08-31 0001719489 klr:SolutionsInfiniMember klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember us-gaap:PreferredStockMember 2021-06-30 0001719489 us-gaap:InterestRateSwapMember 2021-06-30 0001719489 us-gaap:InterestRateSwapMember 2020-12-31 0001719489 country:IT 2021-04-01 2021-06-30 0001719489 country:IT 2020-04-01 2020-06-30 0001719489 country:IT 2021-01-01 2021-06-30 0001719489 country:IT 2020-01-01 2020-06-30 0001719489 stpr:IN 2021-04-01 2021-06-30 0001719489 stpr:IN 2020-04-01 2020-06-30 0001719489 stpr:IN 2021-01-01 2021-06-30 0001719489 stpr:IN 2020-01-01 2020-06-30 0001719489 country:US 2021-04-01 2021-06-30 0001719489 country:US 2020-04-01 2020-06-30 0001719489 country:US 2021-01-01 2021-06-30 0001719489 country:US 2020-01-01 2020-06-30 0001719489 klr:EuropeExcludingItalyMember 2021-04-01 2021-06-30 0001719489 klr:EuropeExcludingItalyMember 2020-04-01 2020-06-30 0001719489 klr:EuropeExcludingItalyMember 2021-01-01 2021-06-30 0001719489 klr:EuropeExcludingItalyMember 2020-01-01 2020-06-30 0001719489 srt:SouthAmericaMember 2021-04-01 2021-06-30 0001719489 srt:SouthAmericaMember 2021-01-01 2021-06-30 0001719489 klr:OtherCountriesMember 2021-04-01 2021-06-30 0001719489 klr:OtherCountriesMember 2020-04-01 2020-06-30 0001719489 klr:OtherCountriesMember 2021-01-01 2021-06-30 0001719489 klr:OtherCountriesMember 2020-01-01 2020-06-30 0001719489 country:IT us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-04-01 2021-06-30 0001719489 country:IT us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-04-01 2020-06-30 0001719489 country:IT us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-06-30 0001719489 country:IT us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-01-01 2020-06-30 0001719489 stpr:IN us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-04-01 2021-06-30 0001719489 stpr:IN us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-04-01 2020-06-30 0001719489 stpr:IN us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-06-30 0001719489 stpr:IN us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-01-01 2020-06-30 0001719489 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-04-01 2021-06-30 0001719489 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-04-01 2020-06-30 0001719489 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-06-30 0001719489 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-01-01 2020-06-30 0001719489 klr:EuropeExcludingItalyMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-04-01 2021-06-30 0001719489 klr:EuropeExcludingItalyMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-04-01 2020-06-30 0001719489 klr:EuropeExcludingItalyMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-06-30 0001719489 klr:EuropeExcludingItalyMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-01-01 2020-06-30 0001719489 srt:SouthAmericaMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-04-01 2021-06-30 0001719489 srt:SouthAmericaMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-04-01 2020-06-30 0001719489 srt:SouthAmericaMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-06-30 0001719489 srt:SouthAmericaMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-01-01 2020-06-30 0001719489 klr:OtherCountriesMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-04-01 2021-06-30 0001719489 klr:OtherCountriesMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-04-01 2020-06-30 0001719489 klr:OtherCountriesMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-06-30 0001719489 klr:OtherCountriesMember us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2020-01-01 2020-06-30 0001719489 country:IT 2021-06-30 0001719489 country:IT 2020-12-31 0001719489 stpr:IN 2021-06-30 0001719489 stpr:IN 2020-12-31 0001719489 country:US 2021-06-30 0001719489 country:US 2020-12-31 0001719489 klr:OtherCountriesMember 2021-06-30 0001719489 klr:OtherCountriesMember 2020-12-31 0001719489 country:IT us-gaap:GeographicConcentrationRiskMember klr:NonCurrentAssetsMember 2021-01-01 2021-06-30 0001719489 country:IT us-gaap:GeographicConcentrationRiskMember klr:NonCurrentAssetsMember 2020-01-01 2020-12-31 0001719489 stpr:IN us-gaap:GeographicConcentrationRiskMember klr:NonCurrentAssetsMember 2021-01-01 2021-06-30 0001719489 stpr:IN us-gaap:GeographicConcentrationRiskMember klr:NonCurrentAssetsMember 2020-01-01 2020-12-31 0001719489 country:US us-gaap:GeographicConcentrationRiskMember klr:NonCurrentAssetsMember 2021-01-01 2021-06-30 0001719489 country:US us-gaap:GeographicConcentrationRiskMember klr:NonCurrentAssetsMember 2020-01-01 2020-12-31 0001719489 klr:OtherCountriesMember us-gaap:GeographicConcentrationRiskMember klr:NonCurrentAssetsMember 2021-01-01 2021-06-30 0001719489 klr:OtherCountriesMember us-gaap:GeographicConcentrationRiskMember klr:NonCurrentAssetsMember 2020-01-01 2020-12-31 0001719489 klr:OfficeMember 2021-04-01 2021-06-30 0001719489 klr:OfficeMember 2021-06-30 0001719489 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001719489 us-gaap:RestrictedStockUnitsRSUMember 2021-06-30 0001719489 us-gaap:RestrictedStockUnitsRSUMember 2021-04-01 2021-06-30 0001719489 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2021-04-01 2021-06-30 0001719489 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-06-30 0001719489 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0001719489 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 0001719489 us-gaap:SellingAndMarketingExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2021-04-01 2021-06-30 0001719489 us-gaap:SellingAndMarketingExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-06-30 0001719489 us-gaap:SellingAndMarketingExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0001719489 us-gaap:SellingAndMarketingExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 0001719489 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2021-04-01 2021-06-30 0001719489 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-06-30 0001719489 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0001719489 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 0001719489 us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-06-30 0001719489 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 klr:TaxableYear 0001719489 2019-01-01 2019-12-31 0001719489 2018-01-01 2018-12-31 0001719489 klr:MGageEuropeLtdMember 2021-06-30 0001719489 klr:SolutionsInfiniMember 2021-06-30 0001719489 us-gaap:WarrantMember 2021-06-30 0001719489 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001719489 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001719489 us-gaap:WarrantMember 2021-04-01 2021-06-30 0001719489 klr:EsseEffeAndMayaMember 2021-06-02 0001719489 klr:AccruedInterestMember klr:EsseEffeAndMayaMember 2021-06-02 0001719489 klr:EsseEffeAndMayaMember 2021-06-30 0001719489 klr:EsseEffeAndMayaMember 2020-12-31 0001719489 klr:AccruedInterestMember klr:EsseEffeAndMayaMember 2020-12-31 0001719489 klr:StudioLegaleChiomentiMember klr:LegalServicesMember 2021-04-01 2021-06-30 0001719489 klr:StudioLegaleChiomentiMember klr:LegalServicesMember 2021-01-01 2021-06-30 0001719489 klr:StudioLegaleChiomentiMember klr:LegalServicesMember 2020-04-01 2020-06-30 0001719489 klr:StudioLegaleChiomentiMember klr:LegalServicesMember 2020-01-01 2020-06-30 0001719489 klr:EmployeeMember klr:KaleyraSPAMember 2021-04-01 2021-06-30 0001719489 klr:EmployeeMember klr:KaleyraSPAMember 2021-01-01 2021-06-30 0001719489 klr:EmployeeMember klr:KaleyraSPAMember 2020-04-01 2020-06-30 0001719489 klr:EmployeeMember klr:KaleyraSPAMember 2020-01-01 2020-06-30 0001719489 klr:PietroCalogeroMember klr:KaleyraSPAMember 2021-04-01 2021-06-30 0001719489 klr:PietroCalogeroMember klr:KaleyraSPAMember 2021-01-01 2021-06-30 0001719489 klr:PietroCalogeroMember klr:KaleyraSPAMember 2020-04-01 2020-06-30 0001719489 klr:PietroCalogeroMember klr:KaleyraSPAMember 2020-01-01 2020-06-30 0001719489 klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember klr:SolutionsInfiniMember srt:ExecutiveOfficerMember 2020-03-31 0001719489 klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember klr:SolutionsInfiniMember srt:ExecutiveOfficerMember 2020-08-31 0001719489 klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember klr:SolutionsInfiniMember srt:ExecutiveOfficerMember 2020-11-30 0001719489 klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember klr:SolutionsInfiniMember srt:ExecutiveOfficerMember 2020-01-01 2020-03-31 0001719489 us-gaap:PreferredStockMember klr:ModificationOf2018SolutionsInfiniPurchaseAgreementMember klr:SolutionsInfiniMember srt:ExecutiveOfficerMember 2021-02-03 0001719489 us-gaap:ResearchAndDevelopmentExpenseMember 2021-04-01 2021-06-30 0001719489 us-gaap:ResearchAndDevelopmentExpenseMember 2020-04-01 2020-06-30 0001719489 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-06-30 0001719489 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-06-30 0001719489 us-gaap:SellingAndMarketingExpenseMember 2021-04-01 2021-06-30 0001719489 us-gaap:SellingAndMarketingExpenseMember 2020-04-01 2020-06-30 0001719489 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-06-30 0001719489 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-06-30 0001719489 us-gaap:GeneralAndAdministrativeExpenseMember 2020-04-01 2020-06-30 0001719489 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-06-30 0001719489 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-06-30 0001719489 klr:FinancialIncomeExpenseNetMember 2021-04-01 2021-06-30 0001719489 klr:FinancialIncomeExpenseNetMember 2020-04-01 2020-06-30 0001719489 klr:FinancialIncomeExpenseNetMember 2021-01-01 2021-06-30 0001719489 klr:FinancialIncomeExpenseNetMember 2020-01-01 2020-06-30 0001719489 us-gaap:SubsequentEventMember klr:MGageEuropeLtdMember 2021-07-31 0001719489 us-gaap:SubsequentEventMember klr:MGageSADeSVMember 2021-07-31 0001719489 klr:BandyerSrlMember us-gaap:SubsequentEventMember 2021-07-08 2021-07-08

  

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2021 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-38320

 

KALEYRA, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

82-3027430

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification Number)

 

Via Marco D’Aviano, 2, Milano MI, Italy

 

20131

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: +39 02 288 5841

(Former name or former address, if changed since last report): N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by checkmark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

 

Large accelerated filer

 

 

Accelerated filer

Non-accelerated filer

 

 

Smaller reporting company

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  ☒

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbols

 

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

KLR

 

NYSE American LLC

Warrants, at an exercise price of $11.50 per share of Common Stock

 

KLR WS

 

NYSE American LLC

 

As of August 3, 2021, there were 41,307,336 shares of the Company’s common stock issued and outstanding.

 


 

 

KALEYRA, INC.

Quarterly Report on Form 10-Q

Table of Contents

 

PART I – FINANCIAL INFORMATION

Page

 

 

Item 1.

Condensed Consolidated Financial Statements (unaudited):

1

 

 

 

 

Condensed Consolidated Balance Sheets

1

 

 

 

 

Condensed Consolidated Statements of Operations

2

 

 

 

 

Condensed Consolidated Statements of Comprehensive Loss

3

 

 

 

 

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

4

 

 

 

 

Condensed Consolidated Statements of Cash Flows

7

 

 

 

 

Notes to Condensed Consolidated Financial Statements

9

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

31

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

43

 

 

 

Item 4.

Controls and Procedures

43

 

 

 

PART II – OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

44

 

 

 

Item 1A.

Risk Factors

45

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

47

 

 

 

Item 3.

Defaults Upon Senior Securities

47

 

 

 

Item 4.

Mine Safety Disclosures

47

 

 

 

Item 5.

Other Information

47

 

 

 

Item 6.

Exhibits

48

 

 

 

Signatures

49

 

 

 


 

Item 1 – Financial Statements

KALEYRA, INC.

Condensed Consolidated Balance Sheets

(Unaudited, in thousands, except share and per share data)

 

 

 

June 30, 2021

 

 

December 31, 2020

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

118,625

 

 

$

32,970

 

Short-term investments

 

 

6,099

 

 

 

4,843

 

Trade receivables, net

 

 

77,252

 

 

 

43,651

 

Prepaid expenses

 

 

3,850

 

 

 

1,447

 

Deferred costs

 

 

371

 

 

 

 

Other current assets

 

 

3,668

 

 

 

2,134

 

Total current assets

 

 

209,865

 

 

 

85,045

 

Property and equipment, net

 

 

15,939

 

 

 

6,726

 

Intangible assets, net

 

 

133,525

 

 

 

7,574

 

Goodwill

 

 

96,788

 

 

 

16,657

 

Deferred tax assets

 

 

 

 

 

703

 

Other long-term assets

 

 

313

 

 

 

1,797

 

Total Assets

 

$

456,430

 

 

$

118,502

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

66,765

 

 

$

51,768

 

Debt for forward share purchase agreements

 

 

 

 

 

483

 

Notes payable due to related parties

 

 

 

 

 

7,500

 

Lines of credit

 

 

5,338

 

 

 

5,273

 

Current portion of bank and other borrowings

 

 

9,448

 

 

 

10,798

 

Deferred revenue

 

 

10,775

 

 

 

3,666

 

Payroll and payroll related accrued liabilities

 

 

4,124

 

 

 

3,292

 

Other current liabilities

 

 

6,647

 

 

 

5,988

 

Total current liabilities

 

 

103,097

 

 

 

88,768

 

Long-term portion of bank and other borrowings

 

 

28,611

 

 

 

31,974

 

Long-term portion of notes payable

 

 

189,238

 

 

 

2,700

 

Long-term portion of employee benefit obligation

 

 

1,952

 

 

 

1,886

 

Deferred tax liability

 

 

1,792

 

 

 

 

Other long-term liabilities

 

 

1,667

 

 

 

603

 

Total Liabilities

 

 

326,357

 

 

 

125,931

 

Commitments and contingencies (Note 15)

 

 

 

 

 

 

 

 

Stockholders’ equity (deficit):

 

 

 

 

 

 

 

 

Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; no shares issued or outstanding

 

 

 

 

 

 

Common stock, par value of $0.0001 per share; 100,000,000 shares authorized as of June 30, 2021 and December 31, 2020; 44,105,394 shares issued and 41,307,336 shares outstanding as of June 30, 2021 and 33,086,745 shares issued and 30,288,687 shares outstanding as of December 31, 2020

 

 

4

 

 

 

3

 

Additional paid-in capital

 

 

245,452

 

 

 

93,628

 

Treasury stock, at cost; 2,798,058 shares as of June 30, 2021 and December 31, 2020

 

 

(30,431

)

 

 

(30,431

)

Accumulated other comprehensive loss

 

 

(2,304

)

 

 

(2,826

)

Accumulated deficit

 

 

(82,648

)

 

 

(67,803

)

Total stockholders’ equity (deficit)

 

 

130,073

 

 

 

(7,429

)

Total liabilities and stockholders’ equity (deficit)

 

$

456,430

 

 

$

118,502

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

1


 

KALEYRA, INC.

Condensed Consolidated Statements of Operations

(Unaudited, in thousands, except share and per share data)

 

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Revenue

 

$

53,992

 

 

$

31,199

 

 

$

93,706

 

 

$

64,832

 

Cost of revenue

 

 

43,529

 

 

 

26,846

 

 

 

76,919

 

 

 

55,748

 

Gross profit

 

 

10,463

 

 

 

4,353

 

 

 

16,787

 

 

 

9,084

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

4,282

 

 

 

2,346

 

 

 

7,150

 

 

 

5,156

 

Sales and marketing

 

 

4,660

 

 

 

2,989

 

 

 

7,519

 

 

 

6,732

 

General and administrative

 

 

12,364

 

 

 

6,537

 

 

 

22,966

 

 

 

14,296

 

Total operating expenses

 

 

21,306

 

 

 

11,872

 

 

 

37,635

 

 

 

26,184

 

Loss from operations

 

 

(10,843

)

 

 

(7,519

)

 

 

(20,848

)

 

 

(17,100

)

Other income, net

 

 

47

 

 

 

11

 

 

 

92

 

 

 

53

 

Financial expense, net

 

 

(908

)

 

 

(518

)

 

 

(1,627

)

 

 

(559

)

Foreign currency income (loss)

 

 

(191

)

 

 

(415

)

 

 

164

 

 

 

(247

)

Loss before income tax benefit

 

 

(11,895

)

 

 

(8,441

)

 

 

(22,219

)

 

 

(17,853

)

Income tax benefit

 

 

(7,408

)

 

 

(313

)

 

 

(7,374

)

 

 

(902

)

Net loss

 

$

(4,487

)

 

$

(8,128

)

 

$

(14,845

)

 

$

(16,951

)

Net loss per common share, basic and diluted

 

$

(0.13

)

 

$

(0.39

)

 

$

(0.46

)

 

$

(0.84

)

Weighted-average shares used in computing net loss per common share, basic and diluted

 

 

34,292,874

 

 

 

20,606,816

 

 

 

32,328,909

 

 

 

20,293,203

 

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2


 

KALEYRA, INC.

Condensed Consolidated Statements of Comprehensive Loss

(Unaudited, in thousands)

 

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net loss

 

$

(4,487

)

 

$

(8,128

)

 

$

(14,845

)

 

$

(16,951

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

(602

)

 

 

(691

)

 

 

503

 

 

 

(1,193

)

Net change in unrealized gain on marketable securities, net of tax

 

 

23

 

 

 

 

 

 

19

 

 

 

4

 

Total other comprehensive income (loss)

 

 

(579

)

 

 

(691

)

 

 

522

 

 

 

(1,189

)

Total comprehensive loss

 

$

(5,066

)

 

$

(8,819

)

 

$

(14,323

)

 

$

(18,140

)

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3


 

 

KALEYRA, INC.

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(Unaudited, in thousands, except share data)

 

 

 

Three Months Ended June 30, 2021

 

 

 

Common Stock

 

 

Additional

Paid-in

 

 

Treasury Stock

 

 

Accumulated

Other

Comprehensive

 

 

Accumulated

 

 

Total

Stockholders'

Equity

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Income (Loss)

 

 

Deficit

 

 

(Deficit)

 

Balance as of March 31, 2021

 

 

30,930,617

 

 

$

3

 

 

$

122,252

 

 

 

2,798,058

 

 

$

(30,431

)

 

$

(1,725

)

 

$

(78,161

)

 

$

11,938

 

Stock-based compensation (RSUs)

 

 

376,719

 

 

 

 

 

 

5,318

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,318

 

Proceeds from issuance of common stock in Private Investment in Public Equity offering, net of issuance costs

 

 

8,400,000

 

 

 

1

 

 

 

99,050

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

99,051

 

Common stock issued to Vivial equity holders (mGage acquisition) (1)

 

 

1,600,000

 

 

 

 

 

 

18,832

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18,832

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,487

)

 

 

(4,487

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(579

)

 

 

 

 

 

(579

)

Balance as of June 30, 2021

 

 

41,307,336

 

 

$

4

 

 

$

245,452

 

 

 

2,798,058

 

 

$

(30,431

)

 

$

(2,304

)

 

$

(82,648

)

 

$

130,073

 

 

 

 

 

Three Months Ended June 30, 2020

 

 

 

Common Stock

 

 

Additional

Paid-in

 

 

Treasury Stock

 

 

Accumulated

Other

Comprehensive

 

 

Accumulated

 

 

Total

Stockholders'

Equity

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Income (Loss)

 

 

Deficit

 

 

(Deficit)

 

Balance as of March 31, 2020

 

 

20,019,048

 

 

$

2

 

 

$

11,190

 

 

 

235,169

 

 

$

(2,587

)

 

$

(424

)

 

$

(49,816

)

 

$

(41,635

)

Common stock repurchased in connection with forward share purchase agreements

 

 

(2,023,341

)

 

 

 

 

 

21,631

 

 

 

2,023,341

 

 

 

(21,631

)

 

 

 

 

 

 

 

 

 

Change in forward share purchase agreement liability

 

 

 

 

 

 

 

 

1,942

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,942

 

Stock-based compensation (RSUs)

 

 

22,000

 

 

 

 

 

 

4,630

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,630

 

Proceeds from issuance of common stock in public offering, net of issuance costs

 

 

7,777,778

 

 

 

1

 

 

 

31,996

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

31,997

 

Common stock issued to sellers (Earn-out 2019)

 

 

1,763,633

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued to settle a payable (2)

 

 

440,595

 

 

 

 

 

 

2,895

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,895

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(8,128

)

 

 

(8,128

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(691

)

 

 

 

 

 

(691

)

Balance as of June 30, 2020

 

 

27,999,713

 

 

$

3

 

 

$

74,284

 

 

 

2,258,510

 

 

$

(24,218

)

 

$

(1,115

)

 

$

(57,944

)

 

$

(8,990

)

4


 

 

 

 

 

 

Six Months Ended June 30, 2021

 

 

 

Common Stock

 

 

Additional

Paid-in

 

 

Treasury Stock

 

 

Accumulated

Other

Comprehensive

 

 

Accumulated

 

 

Total

Stockholders'

Equity

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Income (Loss)

 

 

Deficit

 

 

(Deficit)

 

Balance as of December 31, 2020

 

 

30,288,687

 

 

$

3

 

 

$

93,628

 

 

 

2,798,058

 

 

$

(30,431

)

 

$

(2,826

)

 

$

(67,803

)

 

$

(7,429

)

Conversion of Cowen Note

 

 

303,171

 

 

 

 

 

 

2,295

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,295

 

Forfeiture of 2020 Sponsors' Earnout Shares (3)

 

 

(469,343

)

 

 

 

 

 

1,244

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,244

 

Forward share purchase agreement transactions

 

 

 

 

 

 

 

 

17,528

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17,528

 

Stock-based compensation (RSUs)

 

 

935,115

 

 

 

 

 

 

10,329

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,329

 

Warrants exercised for common stock

 

 

249,706

 

 

 

 

 

 

2,872

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,872

 

Fair value of warrants

 

 

 

 

 

 

 

 

(326

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(326

)

Proceeds from issuance of common stock in Private Investment in Public Equity offering, net of issuance costs

 

 

8,400,000

 

 

 

1

 

 

 

99,050

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

99,051

 

Common stock issued to Vivial equity holders (mGage acquisition) (1)

 

 

1,600,000

 

 

 

 

 

 

18,832

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18,832

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(14,845

)

 

 

(14,845

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

522

 

 

 

 

 

 

522

 

Balance as of June 30, 2021

 

 

41,307,336

 

 

$

4

 

 

$

245,452

 

 

 

2,798,058

 

 

$

(30,431

)

 

$

(2,304

)

 

$

(82,648

)

 

$

130,073

 

 

 

 

 

Six Months Ended June 30, 2020

 

 

 

Common Stock

 

 

Additional

Paid-in

 

 

Treasury Stock

 

 

Accumulated

Other

Comprehensive

 

 

Accumulated

 

 

Total

Stockholders'

Equity

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Shares

 

 

Amount

 

 

Income (Loss)

 

 

Deficit

 

 

(Deficit)

 

Balance as of December 31, 2019

 

 

19,977,113

 

 

$

2

 

 

$

2,143

 

 

 

 

 

$

 

 

$

74

 

 

$

(40,993

)

 

$

(38,774

)

Common stock repurchased in connection with forward share purchase agreements

 

 

(2,258,510

)

 

 

 

 

 

24,218

 

 

 

2,258,510

 

 

 

(24,218

)

 

 

 

 

 

 

 

 

 

Change in forward share purchase agreement liability

 

 

 

 

 

 

 

 

1,671

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,671

 

Stock-based compensation (RSUs)

 

 

159,104

 

 

 

 

 

 

10,834

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,834

 

Proceeds from issuance of common stock in public offering, net of issuance costs

 

 

7,777,778

 

 

 

1

 

 

 

31,996

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

31,997

 

Common stock issued to sellers (Earn-out 2019)

 

 

1,763,633

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued to settle a payable (2) (4)

 

 

580,595

 

 

 

 

 

 

3,422

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,422

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(16,951

)

 

 

(16,951

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,189

)

 

 

 

 

 

(1,189

)

Balance as of June 30, 2020

 

 

27,999,713

 

 

$

3

 

 

$

74,284

 

 

 

2,258,510

 

 

$

(24,218

)

 

$

(1,115

)

 

$

(57,944

)

 

$

(8,990

)

 

____________________

 

(1)

On June 1, 2021, Kaleyra completed its acquisition of mGage for a total purchase price of $218.0 million, consisting of both cash and common stock consideration. The cash consideration amounted to $199.2 million of which $198.6 million was paid on June 1, 2021 and the remaining amount is expected to be settled in fiscal 2021. The common stock consideration was paid with the issuance to Vivial’s former equity holders of a total of 1,600,000 shares of Kaleyra common stock at $11.77 per share closing price of Kaleyra common stock on the date of issuance, equal to $18.8 million.

5


 

 

(2)

On May 1, 2020, the Company issued to Cowen Investments II LLC (“Cowen”) and Chardan Capital Markets, LLC (“Chardan”) an aggregate of 440,595 shares of the Company’s common stock (“Settlement Shares”), consisting of 374,506 Settlement Shares issued to Cowen, and 66,089 Settlement Shares issued to Chardan, as a partial settlement of the amounts owed to Cowen and Chardan for financial advisory services provided by Cowen and Chardan to Kaleyra S.p.A. in connection with the previously consummated Business Combination.

 

(3)

On March 16, 2021, upon the final determination that GigAcquisitions, LLC, Cowen Investments II LLC, Irwin Silverberg and Jeffrey Bernstein (the “Sponsors”) were not entitled to receive the final 50% of the Earnout Shares (“2020 Sponsors’ Earnout Shares”) pursuant to the terms of the Purchase Agreement entered into on February 22, 2019, such number of 2020 Sponsors’ Earnout Shares that have not vested have been forfeited by all but one Sponsor. That Sponsor has agreed with Kaleyra to cash settle their portion of the 2020 Sponsors’ Earnout Shares in lieu of forfeiting their shares.

 

(4)

On March 6, 2020, the Company issued to Northland Securities Inc. (“Northland”) 140,000 shares of the Company’s common stock as a partial settlement of the amounts owned to Northland for financial advisory services provided by Northland to Kaleyra S.p.A. in connection with the previously consummated Business Combination.

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6


 

KALEYRA, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited, in thousands)

 

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(14,845

)

 

$

(16,951

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

3,460

 

 

 

1,269

 

Stock-based compensation, preference shares and others

 

 

9,270

 

 

 

11,133

 

Non-cash settlement of preference share liability

 

 

 

 

 

(2,486

)

Provision for doubtful accounts

 

 

808

 

 

 

44

 

Realized gains on marketable securities

 

 

21

 

 

 

 

Employee benefit obligation

 

 

122

 

 

 

253

 

Change in fair value of warrant liability

 

 

830

 

 

 

 

Reversal of accrued interest on forward share purchase agreement

 

 

(659

)

 

 

 

Non-cash interest expense

 

 

325

 

 

 

117

 

Deferred taxes

 

 

(6,804

)

 

 

(636

)

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

Trade receivables

 

 

(7,259

)

 

 

793

 

Other current assets

 

 

(2,359

)

 

 

1,938

 

Deferred costs

 

 

46

 

 

 

 

Other long-term assets

 

 

1,483

 

 

 

(448

)

Accounts payable

 

 

(1,882

)

 

 

(5,375

)

Other current liabilities

 

 

(2,508

)

 

 

5,059

 

Deferred revenue

 

 

6,920

 

 

 

171

 

Long-term liabilities

 

 

(82

)

 

 

698

 

Net cash used in operating activities

 

 

(13,113

)

 

 

(4,421

)

Cash Flows from Investing Activities:

 

 

 

 

 

 

 

 

Purchase of short-term investments

 

 

(1,882

)

 

 

(4,920

)

Sale of short-term investments

 

 

546

 

 

 

5,041

 

Purchase of property and equipment

 

 

(177

)

 

 

(494

)

Sale of property and equipment

 

 

 

 

 

16

 

Capitalized software development costs

 

 

(1,633

)

 

 

(1,371

)

Purchase of intangible assets

 

 

(3

)

 

 

(6

)

Acquisition of mGage, net of cash acquired

 

 

(195,709

)

 

 

 

Net cash used in investing activities

 

 

(198,858

)

 

 

(1,734

)

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

 

Proceeds from (repayments on) line of credit, net

 

 

203

 

 

 

1,353

 

Borrowings on term loans

 

 

 

 

 

8,800

 

Repayments on term loans

 

 

(3,451

)

 

 

(5,741

)

Proceeds from issuance of convertible notes, net of issuance costs

 

 

188,637

 

 

 

 

Repayments on notes

 

 

(7,500

)

 

 

(5,478

)

Repurchase of common stock in connection with forward share purchase agreements

 

 

 

 

 

(24,218

)

Receipts (payments) related to forward share purchase agreements

 

 

17,045

 

 

 

(620

)

Proceeds from issuance of common stock in Private Investment in Public Equity offering, net of issuance costs

 

 

99,051

 

 

 

32,680

 

Proceeds related to settlement of non-forfeited 2020 Sponsor Earnout Shares

 

 

1,244

 

 

 

 

Proceeds from the exercise of common stock warrants

 

 

2,872

 

 

 

 

Repayments on capital lease

 

 

(66

)

 

 

 

Net cash provided by financing activities

 

 

298,035

 

 

 

6,776

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

(409

)

 

 

(370

)

Net increase in cash, cash equivalents and restricted cash

 

 

85,655

 

 

 

251

 

Cash, cash equivalents and restricted cash, beginning of period

 

 

32,970

 

 

 

36,997

 

Cash, cash equivalents and restricted cash, end of period

 

$

118,625

 

 

$

37,248

 

7


 

Supplemental disclosures of cash flow information:

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

763

 

 

$

448

 

Non-cash investing and financing activities

 

 

 

 

 

 

 

 

Change in value of forward share purchase agreements

 

$

(483

)

 

$

(1,671

)

Common stock issued to settle a payable

 

$

 

 

$

3,123

 

Issuance costs for private and public offering included in accounts payable

 

$

 

 

$

683

 

Common stock issued to Vivial equity holders (mGage acquisition)

 

$

18,832

 

 

$

 

Note payable issued to settle a payable

 

$

 

 

$

3,100

 

Stock-based compensation capitalized as software development costs

 

$

363

 

 

$

 

Conversion of convertible note to common stock

 

$

2,295

 

 

$

 

Fair value of warrant liability

 

$

344

 

 

$

 

Reclassification of warrant liability to additional paid-in capital upon exercise of warrants

 

$

(18

)

 

$

 

Consideration payable related to the acquisition of mGage

 

$

633

 

 

$

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

8


 

KALEYRA, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Kaleyra, Inc., formerly GigCapital, Inc., (“Kaleyra,” the “Company,” “we,” “us,” and “our” refer to Kaleyra, Inc. and all of its consolidated subsidiaries) was incorporated in Delaware on October 9, 2017. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

On February 22, 2019, the Company entered into a stock purchase agreement (the “Stock Purchase Agreement”) by and among the Company, Kaleyra S.p.A., Shareholder Representative Services LLC, as representative for the holders of the ordinary shares of Kaleyra S.p.A. immediately prior to the closing of a business combination (the “Business Combination”), and all of the stockholders of all of the Kaleyra S.p.A. stock (collectively, such Kaleyra S.p.A. stockholders, the “Sellers”), for the purpose of the Company acquiring all of the shares of Kaleyra S.p.A.

As a result of the Business Combination, which closed on November 25, 2019, the Company (headquartered in Milan, Italy) became a cloud communications software provider delivering secure Application Protocol Interfaces (“APIs”) and user interface based tools for business-to-consumer communications on a global basis. Kaleyra operates in the Communication Platform as a Service (“CPaaS”) market with operations in Italy, India, Dubai and the United States.

Kaleyra’s underlying technology used in the platform is the same across all of its communication services which can generally be described as “omni-channel mobile first interactive notifications via a public or private cloud implementation”. These services include programmable voice/Interactive Voice Response (IVR) configurations, inbound/outbound messaging capabilities, hosted telephone numbers, conversational marketing solutions, and other types of IP communications services such as e-mail, push notifications, and WhatsApp®.

On February 18, 2021, Kaleyra entered into an agreement and plan of merger (the “Merger Agreement”) with Vivial, Inc. (“Vivial”) for the acquisition of the business known as mGage (“mGage”), a leading global mobile messaging provider (the transaction contemplated by the Merger Agreement, the “Merger”).

On June 1, 2021, Kaleyra completed its acquisition of mGage for a total purchase price of $218.0 million. The Merger consideration consisted of both cash consideration and common stock consideration. The cash consideration amounted to $199.2 million of which $198.6 million was paid on June 1, 2021 and the remaining amount is expected to be settled in fiscal 2021. The common stock consideration was paid with the issuance to Vivial’s former equity holders of a total of 1,600,000 shares of Kaleyra common stock at the $11.77 per share closing price of Kaleyra common stock on the date of issuance, equal to $18.8 million. In support of the consummation of the Merger, on February 18, 2021, Kaleyra entered into subscription agreements (the “PIPE Subscription Agreements”), with certain institutional investors (the “PIPE Investors”), pursuant to which, among other things, Kaleyra agreed to issue and sell, in private placements to close immediately prior to the closing of the Merger, an aggregate of 8,400,000 shares of Kaleyra common stock to the PIPE Investors at $12.50 per share. Kaleyra also entered into convertible note subscription agreements (the “Convertible Note Subscription Agreements”) with certain institutional investors (the “Convertible Note Investors”), pursuant to which Kaleyra agreed to issue and sell, in private placements to close immediately prior to the closing of the Merger, $200 million aggregate principal amount of unsecured convertible notes (the “Merger Convertible Notes”).

Subsequent to June 30, 2021, Kaleyra announced the acquisition of Bandyer Srl (“Bandyer”). Bandyer offers cloud-based audio/video communications services via Web Real Time Communication (“WebRTC”) technology to financial institutions, retail companies, utilities, industries, insurance, human resources and digital healthcare organizations. Bandyer has been serving customers with programmable audio/video APIs and Software Development Kits (“SDKs”) based on WebRTC technology for a variety of use cases including group video calls and webinars.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company are unaudited, and have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, this interim quarterly financial report does not include all disclosures required by US GAAP. In the opinion of our management, the unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, considered necessary to present fairly the financial position, results of operations and cash flows of Kaleyra and our consolidated subsidiaries for all periods presented. The results of operations for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be

9


 

expected in the future or for the full fiscal year. It is recommended that these condensed consolidated financial statements be read in conjunction with our consolidated financial statements and the notes thereto included in our 2020 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 16, 2021.

These condensed consolidated financial statements have been prepared in conformity with US GAAP applicable for an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (“JOBS Act”). The JOBS Act provides, among others, that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. In particular, an emerging growth company can delay the adoption of certain accounting standards until those standards would apply to private companies. For the purpose of these condensed consolidated financial statements, the Company availed itself of an extended transition period for complying with new or revised accounting standards and, as a result, did not adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for public companies.

Liquidity

The Company evaluated its ability to continue as a going concern. The Company has negative cash flows from operating activities through June 30, 2021. The condensed consolidated balance sheet as of June 30, 2021 includes total current assets of $209.9 million and total current liabilities of $103.1 million, resulting in net current assets of $106.8 million.

The Business Combination generated significant obligations including (i) $13.1 million of liabilities related to non-recurring Business Combination transaction related costs; (ii) $15.0 million of deferred consideration to the Sellers in the Business Combination transaction; (iii) $13.2 million of net obligations under certain Shares Purchase Forward Agreements entered into by GigCapital, Inc. prior to the Business Combination; and (iv) $3.6 million of notes payable acquired as a result of the Business Combination. As of June 30, 2021, the Company only had $405,000 of remaining obligations as a result of the Business Combination.

On February 18, 2021, and for the purposes of raising the cash portion of the consideration for the Merger, Kaleyra entered into the PIPE Subscription Agreements with the PIPE Investors and the Convertible Note Subscription Agreements with the Convertible Note Investors. Pursuant to these agreements, and prior to the closing of the Merger on June 1, 2021, Kaleyra issued and sold in private placements an aggregate of $105 million or 8,400,000 shares of Kaleyra common stock to the PIPE Investors at $12.50 per share, and $200 million aggregate principal amount of unsecured Merger Convertible Notes.

Considering the effects of the financings described above and the typical financial cycle of Kaleyra, Kaleyra’s management believes that the Company’s cash and availability of borrowings, will be sufficient to support its planned operations for at least the next 12 months from the date these condensed consolidated financial statements were issued.

Business seasonality

Historically, Kaleyra has experienced clear seasonality in its revenue generation, with slower traction in the first calendar quarter, and increasing revenues as the year progresses toward the higher revenues in messaging and notification services during the fourth calendar quarter. This patterned revenue generation behavior takes place due to Kaleyra’s customers sending more messages to their end-user customers who are engaged in consumer transactions at the end of the calendar year, resulting in an increase in notifications of electronic payments, credit card transactions and e-commerce orders.

Principles of Consolidation

The condensed consolidated financial statements include the Company and its wholly owned subsidiaries, including Kaleyra S.p.A., Solutions Infini, Buc Mobile, The Campaign Registry and mGage, which represent its major operations. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are used for, but not limited to, allowance for doubtful accounts; valuation of the Company’s stock-based awards; recoverability of long-lived and intangible assets; capitalization and useful life of the Company’s capitalized internal-use software development costs; fair values and estimated lives of acquired intangible assets; accruals and contingencies, including tax related provision and valuation allowance on deferred taxes. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. However, future events are subject to change and best estimates and judgments may require further adjustments; therefore, actual results could differ materially from those estimates. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment due to the recent outbreak of a novel strain of the coronavirus (“COVID-19”).

10


 

Concentration of Credit Risk

Financial instruments that potentially expose the Company to a concentration of credit risk consist primarily of cash, restricted cash and cash equivalents, short-term investments and trade receivables. The Company maintains cash and cash equivalents and short-term investments with financial institutions that management believes are financially sound.

The Company sells its services to a wide variety of customers. If the financial condition or results of operations of any significant customers deteriorate substantially, operating results could be adversely affected. To reduce credit risk, management performs ongoing credit evaluations of the financial condition of significant customers. The Company maintains reserves for estimated credit losses on customer accounts when considered necessary. Actual credit losses may differ from the Company’s estimates. In the three months ended June 30, 2021 and 2020, there were zero and one customer, respectively, that individually accounted for more than 10% of the Company’s consolidated total revenue. In the six months ended June 30, 2021 and 2020, there were no customers that individually accounted for more than 10% of the Company’s consolidated total revenue. In the three months ended June 30, 2020, revenue generated by that one customer accounted for $3.7 million. As of June 30, 2021 and December 31, 2020, one individual customer in both periods accounted for more than 10% of the Company’s consolidated total trade receivables. Trade receivables accounted for by that one customer amounted to $7.9 million as of June 30, 2021 and another customer accounted for $4.5 million in trade receivables as of December 31, 2020.

Warrant Liability

The Company accounts for warrants for shares of the Company’s common stock that are not indexed to its own stock as liabilities at fair value on the condensed consolidated balance sheets. The warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized in “Financial expense, net” on the condensed consolidated statements of operations. The liability is included in the condensed consolidated balance sheet line item “Other long-term liabilities”. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the common stock warrants. At that time, the portion of the warrant liability related to the common stock warrants will be reclassified to additional paid-in capital.

Recent Accounting Pronouncements

In May 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2021-04 “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation— Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815- 40) Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” which clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. An entity should measure the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as follows: i) for a modification or an exchange that is a part of or directly related to a modification or an exchange of an existing debt instrument or line-of-credit or revolving-debt arrangements (hereinafter, referred to as a “debt” or “debt instrument”), as the difference between the fair value of the modified or exchanged written call option and the fair value of that written call option immediately before it is modified or exchanged; ii) for all other modifications or exchanges, as the excess, if any, of the fair value of the modified or exchanged written call option over the fair value of that written call option immediately before it is modified or exchanged. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. The Company is currently evaluating the impact of this standard on its condensed consolidated financial statements.

In January 2021, the FASB issued ASU 2021-01 “Reference Rate Reform (Topic 848)”, which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. Specifically, certain provisions in Topic 848, if elected by an entity, apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. Amendments in this Update to the expedients and exceptions in Topic 848 capture the incremental consequences of the scope clarification and tailor the existing guidance to derivative instruments affected by the discounting transition. The amendments in this Update apply to all entities that elect to apply the optional guidance in Topic 848. The amendments do not apply to contract modifications made after December 31, 2022 or new hedging relationships entered into after December 31, 2022. For existing hedging relationships evaluated for effectiveness in periods after December 31, 2022, an exception is made for those hedging relationships that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship (including periods after December 31, 2022). The Company is currently evaluating the impact of the optional expedients and exceptions of this standard on its condensed consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06 “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” which is aimed to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. In

11


 

addressing the complexity, the FASB focused on amending the guidance on convertible instruments and the guidance on the derivatives scope exception for contracts in an entity’s own equity. For convertible instruments, the Board decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted the amendments in this update as of the beginning of its annual fiscal year 2021, and the adoption did not have a material impact on its condensed consolidated financial statements.

In June 2020, the FASB issued ASU 2020-05 “Revenue from contracts with customers (Topic 606) and Leases (Topic 842): Effective dates for certain entities” (“ASU 2020-05”), which provides a limited one year deferral of the effective dates of the following updates (including amendments issued after the issuance of the original update) to provide immediate, near-term relief for certain entities for whom these updates are either currently effective or imminently effective: i) ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“Revenue”); ii) ASU No. 2016-02, Leases (Topic 842) (“Leases”). In November 2019, the FASB issued ASU 2019-10 “Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates” (“ASU 2019-10”). The amendments in this ASU amended certain effective dates for the above ASU 2016-02, Leases (including amendments issued after the issuance of the original ASU). The effective dates for Leases after applying ASU 2019-10 were as follows: public business entities, excluding emerging growth companies and smaller reporting companies, for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. All other entities for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021. Early application continues to be allowed. In ASU 2019-10, the FASB noted that challenges associated with transition to a major update are often magnified for private companies and smaller public companies. Those challenges have been significantly amplified by the current business and capital market disruptions caused by the COVID-19 pandemic. For this reason, the FASB issued the amendments in ASU 2020-05 by deferring the effective date for one additional year for entities in the “all other” category that have not yet issued their financial statements (or made financial statements available for issuance) reflecting the adoption of Leases. Therefore, under the amendments, Leases (Topic 842) is effective for entities within the “all other” category for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early application continues to be permitted, which means that an entity may choose to implement Leases before those deferred effective dates. While the Company expects the adoption of the Leases standard (Leases Topic 842) to result in a material increase to the reported assets and liabilities, the Company has not yet determined the full impact that the adoption of this standard will have on its condensed consolidated financial statements.

In February 2020, the FASB issued ASU 2020-02 “Financial Instruments—Credit Losses (Topic 326) and Leases (Topic 842), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842). This ASU applies to all registrants that are creditors in loan transactions that, individually or in the aggregate, have a material effect on the registrant’s financial condition. This ASU guidance is applicable upon a registrant’s adoption of Accounting Standards Codification (“ASC”) Topic 326. On November 15, 2019, the FASB delayed the effective date of ASC Topic 326 for certain small public companies and other private companies. As amended, the effective date of ASC Topic 326 was delayed until fiscal years beginning after December 15, 2022 for U.S. Securities and Exchange Commission (“SEC”) filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. The Company is currently evaluating the impact of this standard on its condensed consolidated financial statements.

In November 2019, the FASB issued ASU 2019-10 “Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates”. The amendments in ASU 2019-10 amend certain effective dates for the following major ASUs (including amendments issued after the issuance of the original ASU):

a)ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (Credit Losses) (“ASU 2016-13”). The amendments in this ASU amend the mandatory effective dates for Credit Losses for all entities as follows: Public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. All other entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early application continues to be allowed. The Company is currently evaluating the impact of this standard on its condensed consolidated financial statements.

12


 

b)ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (Hedging). The effective dates for Hedging after applying this ASU are as follows: Public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. All other entities for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021. Early application continues to be allowed. The Company is currently evaluating the impact of this standard on its condensed consolidated financial statements.

In August 2018, the FASB issued ASU 2018-15, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract”. This standard aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The standard is effective for public business entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. For all other entities, the amendments in this ASU are effective for annual reporting periods beginning after December 15, 2020, and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted, including adoption in any interim period, for all entities. The amendments in this ASU should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company adopted the amendments, and the adoption did not have a material impact on its condensed consolidated financial statements.

In August 2018, the FASB issued ASU 2018-14, “Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20)”, which modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The amendments are effective for fiscal years ending after December 15, 2020 for public business entities and for fiscal years ending after December 15, 2021 for all other entities. Early adoption is permitted for all entities. The Company adopted the amendments, and the adoption did not have a material impact on its condensed consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, “Simplifying the Test for Goodwill Impairment”, which removes the second step of the goodwill impairment test that requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit's carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. This guidance is effective prospectively for public business entities for annual or interim goodwill impairment tests in fiscal years beginning after December 15, 2020 and for annual or interim goodwill impairment tests in fiscal years beginning after December 15, 2021 for other entities. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company is currently evaluating the impact of this standard on its condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses: Measurement of Credit Losses on Financial Instruments”, which changes the impairment model for most financial assets. The new model uses a forward-looking expected loss method, which will generally result in earlier recognition of allowances for losses. In November 2018, the FASB issued ASU 2018-19, “Codification Improvements to Topic 326, Financial Instruments— Credit Losses”, which clarifies that receivables arising from operating leases are not within the scope of Topic 326, Financial Instruments—Credit Losses. Instead, impairment of receivables arising from operating leases should be accounted for in accordance with Topic 842, Leases. These ASUs are effective for public entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and for other entities for fiscal years beginning after December 15, 2020 and interim periods within fiscal years beginning after December 15, 2021. Earlier application is permitted. As noted above, the effective date of this ASU has now been delayed for two years by the issuance of ASU 2019-10. The Company is currently evaluating the impact of this standard on its condensed consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02, “Leases”, which was further clarified by ASU 2018-10, “Codification Improvements to Topic 842, Leases”, and ASU 2018-11, “Leases—Targeted Improvements”, both issued in July 2018. ASU 2016-02 affects all entities that lease assets and will require lessees to recognize a lease liability and a right-of-use asset for all leases (except for short-term leases that have a duration of less than one year) as of the date on which the lessor makes the underlying asset available to the lessee. For lessors, accounting for leases is substantially the same as in prior periods. ASU 2018-10 clarifies or corrects unintended application of guidance related to ASU 2016-02. The amendment affects narrow aspects of ASU 2016-02 related to the implicit rate in the lease, impairment of the net investment in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. ASU 2018-11 adds a transition option for all entities and a practical expedient only for lessors. The transition option allows entities to not apply the new lease standard in the comparative periods they present in their financial statements in the year of adoption. Under the transition option, entities can opt to continue to apply the legacy guidance in ASC 840, “Leases”, including its disclosure requirements, in the comparative prior periods presented in the year they adopt the new lease standard. Entities that elect this transition option will still be required to adopt the new leases standard using the modified retrospective transition method required by the standard, but they will recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented. The new standards are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years for a public business entity. For all other entities, the amendments in this ASU are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Earlier application is permitted. As noted above, the effective date of this ASU has now been delayed for two years by the issuance of ASU 2020-05. While the Company expects the adoption of these standards to result in a material increase to the reported assets and

13


 

liabilities, the Company has not yet determined the full impact that the adoption of this standard will have on its condensed consolidated financial statements.

3. BUSINESS COMBINATION

Acquisition of mGage

On June 1, 2021, Kaleyra completed its Merger with Vivial and the resulting acquisition of the business owned by Vivial known as mGage, a leading global mobile messaging provider. The acquisition of mGage provided an opportunity for Kaleyra to expand its network operator connections and become one of only four companies providing direct connectivity to all US carriers.

Pursuant to the Merger Agreement dated as of February 18, 2021, by and among Kaleyra, its wholly-owned subsidiary, Volcano Merger Sub, Inc. (“Merger Sub”), Vivial and GSO Special Situations Master Fund LP, solely in its capacity as the Stockholder Representative, Vivial was merged with and into Merger Sub, with Vivial surviving as a wholly-owned subsidiary of Kaleyra. The name of Vivial was changed to mGage Group Holdings, Inc. (“mGage Group Holdings”) as a result of the Merger. Subsequently, on July 1, 2021, this name was again changed to Kaleyra US Inc.

The Merger consideration consisted of cash consideration and common stock consideration. Cash consideration amounted to $199.2 million of which $198.6 million was paid on June 1, 2021 and the remaining amount is expected to be settled in fiscal 2021. The common stock consideration was paid with the issuance to Vivial’s former equity holders of a total of 1,600,000 shares of Kaleyra common stock (the “Parent Common Stock”). The resulting amount, which was based upon the $11.77 per share closing price of Parent Common Stock as of June 1, 2021, was equal to $18.8 million and has been recognized as part of the consideration transferred.

The Merger was financed through (i) the proceeds from the issuance and sale by Kaleyra, of an aggregate of 8,400,000 shares of Kaleyra common stock to PIPE Investors at $12.50 per share, pursuant to the subscription agreements dated February 18, 2021; and (ii) the proceeds from the issuance in a private placement, of $200 million aggregate principal amount of Merger Convertible Notes to certain institutional investors. See Note 10 – Notes Payable for additional details on the Merger Convertible Notes.  

The Merger was accounted for as a business combination and the total fair value of the consideration transferred of $218.0 million was allocated to the net tangible and intangible assets and liabilities based on their fair values as of the acquisition date and the excess was recorded as goodwill. The acquired entity’s results of operations have been included in the condensed consolidated financial statements of the Company from the date of acquisition.

The following table summarizes the fair value amount recognized for the assets acquired and liabilities assumed as of the acquisition date (in thousands):

 

Customer relationships (1)

 

$

78,100

 

Developed technology (1)

 

 

37,100

 

Trade names (1)

 

 

13,000

 

Deferred tax assets on loss carryforward

 

 

31,489

 

Goodwill (2)

 

 

80,336

 

Accounts receivable and other current assets

 

 

29,995

 

Property and equipment

 

 

8,450

 

Cash and cash equivalents

 

 

2,856

 

Total assets acquired

 

 

281,326

 

Deferred tax liabilities

 

 

40,704

 

Accounts payable and other current liabilities

 

 

22,591

 

Total liabilities assumed

 

 

63,295

 

Net assets acquired

 

$

218,031

 

 

(1)

Identified finite-lived intangible assets. The estimated fair value of the intangible assets acquired was determined by the Company, which considered or relied in part upon a valuation report of a third-party expert. The Company used income approaches to estimate the fair values of the identifiable intangible assets. The estimated useful life is 7 to 9 years for customer relationships, 6 years for developed technology and 8 years for trade names.

 

(2)

Goodwill is the excess of fair value of the consideration transferred over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed and represents expected synergies of the combination of the acquired business. Goodwill is not deductible for income tax purposes.

In 2021, the Company incurred costs related to this acquisition of $5.5 million that were expensed in general and administrative expenses in the accompanying consolidated statements of operations.

14


 

The contribution of mGage to the consolidated revenue and consolidated net loss for the month ended June 30, 2021 was $10.2 million and net income of $934,000, respectively.

Unaudited supplemental pro-forma information

The following table presents unaudited supplemental pro-forma information for the three and six months ended June 30, 2021 and 2020 as if the Merger had occurred on January 1, 2020. The main adjustments reflected in the unaudited pro-forma financial information are as follows:

 

(i)

the amortization of intangible assets arising from the purchase price allocation amounting to (i) $2.0 million and $5.0 million for three and six months ended June 30, 2021, respectively, net of the related tax effect of $748,000 and $1.9 million, respectively, which are referred to the period starting on January 1, 2021 through the date of the Merger, and (ii) $3.0 million and $6.1 million for three and six months ended June 30, 2020, respectively, net of the related tax effect of $1.1 million and $2.2 million, respectively, which are referred to the entire periods;

 

(ii)

the financial expenses incurred in connection with the Merger Convertible Notes amounting to (i) $1.9 million and $4.9 million for three and six months ended June 30, 2021, respectively, which are referred to the period starting on January 1, 2021 through the date of the Merger, and (ii) $3.8 million and $7.4 million for three and six months ended June 30, 2020, respectively, which are referred to the entire periods. No pro forma tax benefit has been reflected in connection with the pro forma adjustment to financial income (expense), net as Kaleyra is in a net loss tax position and a valuation allowance would be established for the amount of any deferred tax assets.

Transaction costs incurred in connection with the transactions were not eliminated. The pro-forma financial information is not necessarily indicative of the results of operation that would have occurred had the transactions been affected on the assumed dates.

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Revenue

 

$

76,552

 

 

$

65,831

 

 

$

148,127

 

 

$

134,576

 

Net loss

 

 

(5,440

)

 

 

(5,542

)

 

 

(18,257

)

 

 

(14,257

)

Net loss per common share, basic and diluted

 

 

(0.13

)

 

 

(0.18

)

 

 

(0.45

)

 

 

(0.47

)

Weighted-average shares used in computing net loss per common share, basic and diluted

 

 

41,181,763

 

 

 

30,606,816

 

 

 

40,773,353

 

 

 

30,293,203

 

 

The contribution of mGage to the pro-forma consolidated revenue was $32.7 million and $64.6 million for the three and six months ended June 30, 2021, respectively, and $34.6 million and $69.7 million for the three and six months ended June 30, 2020, respectively.

The contribution of mGage to the pro-forma consolidated net loss was an income of $241,000 and a net loss of $2.2 million for the three and six months ended June 30, 2021, respectively, and an income of $2.6 million and $2.7 million for the three and six months ended June 30, 2020, respectively.

4. FAIR VALUE MEASUREMENTS

The following tables provide the assets and liabilities measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 (in thousands):

 

 

 

Fair Value Hierarchy as of June 30, 2021

 

 

Aggregate

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Fair Value

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mutual funds (1)

 

$

591

 

 

$

 

 

$

 

 

$

591

 

Certificates of deposit (2)

 

 

 

 

 

5,508

 

 

 

 

 

 

5,508

 

Total Assets

 

$

591

 

 

$

5,508

 

 

$

 

 

$

6,099

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Rate Swap (3)

 

$

 

 

$

66

 

 

$

 

 

$

66

 

Warrant liability (4)

 

 

 

 

 

1,155

 

 

 

 

 

 

1,155

 

Total Liabilities

 

$

 

 

$

1,221

 

 

$

 

 

$

1,221

 

 

(1)

Included in the condensed consolidated balance sheet line item “Short-term investments”.

15


 

 

 

(2)

Included in the condensed consolidated balance sheet line item “Short-term investments”, with maturity terms between 4 and 12 months held in India.

 

(3)

Included in the condensed consolidated balance sheet line item “Other long-term liabilities”.

 

(4)

Included in the condensed consolidated balance sheet line item “Other long-term liabilities”. See Note 18 – Warrants – for further details.

 

 

 

Fair Value Hierarchy as of December 31, 2020

 

 

Aggregate

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Fair Value

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mutual funds (1)

 

$

590

 

 

$

 

 

$

 

 

$

590

 

Certificates of deposit (2)

 

 

 

 

 

4,253

 

 

 

 

 

 

4,253

 

Total Assets

 

$

590

 

 

$

4,253

 

 

$

 

 

$

4,843

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Rate Swap (3)

 

$

 

 

$

109

 

 

$

 

 

$

109

 

Debt for forward share purchase agreements (4)

 

 

 

 

 

483

 

 

 

 

 

 

483

 

Total Liabilities

 

$

 

 

$

592

 

 

$

 

 

$

592

 

 

(1)

Included in the condensed consolidated balance sheet line item “Short-term investments”.

 

(2)

Included in the condensed consolidated balance sheet line item “Short-term investments”, with maturity terms between 4 and 12 months held in India.

 

(3)

Included in the condensed consolidated balance sheet line item “Other long-term liabilities”.

 

(4)

Based on the information available at the reporting date, debt for forward share purchase agreements have been determined as the present value to be paid at settlement in case the counterparty exercises the put option.

The values of short-term investments as of June 30, 2021 and as of December 31, 2020 were as follows (in thousands):

 

 

 

As of June 30, 2021

 

 

As of December 31, 2020

 

 

 

Cost

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Fair Value

 

 

Cost

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Fair Value

 

Mutual funds

 

$

572

 

 

$

19

 

 

$

 

 

$

591

 

 

$

580

 

 

$

10

 

 

$

 

 

$

590

 

Certificates of deposit

 

 

5,508

 

 

 

 

 

 

 

 

 

5,508

 

 

 

4,253

 

 

 

 

 

 

 

 

 

4,253

 

 

There were no transfers into or out of Level 2 or Level 3 for the three and six months ended June 30, 2021 and the year ended December 31, 2020.

Net realized and unrealized (gains) and losses included in income related to Level 3 liabilities shown above are reported in the condensed consolidated statements of operations as follows (in thousands):

 

 

 

Research

and

Development

 

 

Sales

and

Marketing

 

 

General

and

Administrative

 

 

Financial Income

(Expense), net

 

 

Foreign

Currency

Income (Loss)

 

 

Total

 

Six months ended June 30, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preference shares

 

$

(941

)

 

$

(372

)

 

$

(756

)

 

$

(417

)

 

$

 

 

$

(2,486

)

 

5. DERIVATIVE FINANCIAL INSTRUMENTS

The gross notional amount of interest rate swap derivative contracts not designated as hedging instruments, outstanding as of June 30, 2021 and December 31, 2020, was €7.7 million ($9.1 million) and €9.5 million ($11.6 million), respectively.

The amount and location of the gains (losses) in the condensed consolidated statements of operations related to derivative contracts is as follows (in thousands):

 

16


 

 

 

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

Derivatives Not Designed As Hedging Instruments

 

Line Items

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Interest Rate Swap

 

Financial income (expense), net

 

$

28

 

 

$

(51

)

 

$

41

 

 

$

(44

)

Total

 

 

 

$

28

 

 

$

(51

)

 

$

41

 

 

$

(44

)

 

The following table presents the fair value and the location of derivative contracts reported in the condensed consolidated balance sheets (in thousands):

 

 

 

 

 

As of June 30,

 

 

As of December 31,

 

Derivatives Not Designed As Hedging Instruments

 

Line Items

 

2021

 

 

2020

 

Interest Rate Swap

 

Other long-term liabilities

 

$

66

 

 

$

109

 

Total

 

 

 

$

66

 

 

$

109

 

 

6. GOODWILL AND INTANGIBLE ASSETS, NET

Goodwill

Goodwill as of June 30, 2021 and December 31, 2020 was as follows (in thousands):

 

Balance as of December 31, 2020

 

$

16,657

 

Goodwill additions related to 2021 acquisition

 

 

80,336

 

Effect of exchange rate

 

 

(205

)

Balance as of June 30, 2021

 

$

96,788

 

Intangible assets, net

Intangible assets consisted of the following (in thousands):

 

 

 

As of June 30, 2021

 

 

As of December 31, 2020

 

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net

 

Amortizable Intangible Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

$

39,819

 

 

$

2,389

 

 

$

37,430

 

 

$

2,742

 

 

$

1,576

 

 

$

1,166

 

Customer relationships

 

 

86,920

 

 

 

3,764

 

 

 

83,156

 

 

 

8,925

 

 

 

2,598

 

 

 

6,327

 

Trade names

 

 

13,000

 

 

 

135

 

 

 

12,865

 

 

 

 

 

 

 

 

 

 

Patent

 

 

129

 

 

 

55

 

 

 

74

 

 

 

130

 

 

 

49

 

 

 

81

 

Total amortizable intangible assets

 

$

139,868

 

 

$

6,343

 

 

$

133,525

 

 

$

11,797

 

 

$

4,223

 

 

$

7,574

 

 

Amortization expense was $1.8 million and $406,000 for the three months ended June 30, 2021 and 2020, respectively, and $2.2 million and $828,000 for the six months ended June 30, 2021 and 2020, respectively.

Total estimated future amortization expense as of June 30, 2021 is as follows (in thousands):

 

 

 

As of

June 30, 2021

 

2021 (remaining six months)

 

$

8,900

 

2022

 

 

17,745

 

2023

 

 

17,643

 

2024

 

 

17,442

 

2025

 

 

17,227

 

2026 and thereafter

 

 

54,568

 

Total

 

$

133,525

 

17


 

 

 

7. OTHER ASSETS

Other current assets consisted of the following (in thousands):

 

 

 

As of June 30,

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

VAT receivables

 

$

875

 

 

$

1,347

 

Receivables from suppliers

 

 

1,282

 

 

 

542

 

Credit for tax other than income tax

 

 

886

 

 

 

119

 

Income tax receivables

 

 

96

 

 

 

69

 

Other receivables

 

 

529

 

 

 

57

 

Total other current assets

 

$

3,668

 

 

$

2,134

 

 

Other long-term assets consisted of the following (in thousands):

 

 

 

As of June 30,

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Non-current income tax credit (advances and tax reduced at sources)

 

$

53

 

 

$

1,509

 

Miscellaneous

 

 

260

 

 

 

288

 

Total other long-term assets

 

$

313

 

 

$

1,797

 

 

8. BANK AND OTHER BORROWINGS

Credit line facilities

As of June 30, 2021, the Company had credit line facilities denominated in Euro for a total amount of $7.5 million, of which $5.3 million had been used. As of December 31, 2020, the Company had credit line facilities denominated in Euro for $7.7 million, of which $5.3 million had been used.

The credit lines denominated in Euro may be drawn upon at variable interest rates in the following range: 0.6% - 7.6%. The weighted average interest rate on those credit line facilities outstanding as of June 30, 2021, was 1.22%.

18


 

Long-term bank and other borrowings

Long-term bank and other borrowings consist of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Nominal Rate

 

 

 

As of

June 30,

 

 

As of

December 31,

 

 

 

 

Interest

 

 

As of

June 30,

 

 

As of

December 31,

 

 

 

2021

 

 

2020

 

 

Maturity

 

Contractual Rate

 

 

2021

 

 

2020

 

UniCredit S.p.A.

   (Line A Tranche 1)

 

$

2,787

 

 

$

3,235

 

 

July 2023

 

Euribor 3 months + 3.10%

 

 

 

2.80

%

 

 

2.80

%

UniCredit S.p.A.

   (Line A Tranche 2)

 

 

133

 

 

 

153

 

 

November 2023

 

Euribor 3 months + 3.10%

 

 

 

2.80

%

 

 

2.80

%

UniCredit S.p.A. (Line B)

 

 

2,691

 

 

 

3,030

 

 

May 2024

 

Euribor 3 months + 2.90%

 

 

 

2.60

%

 

 

2.60

%

UniCredit S.p.A. (Line C)

 

 

2,182

 

 

 

2,521

 

 

August 2023

 

Euribor 3 months + 3.90%

 

 

 

3.36

%

 

 

3.36

%

Intesa Sanpaolo S.p.A.

   (Line 1)

 

 

603

 

 

 

931

 

 

April 2022

 

Euribor 3 months + 1.80%

 

 

 

1.26

%

 

 

1.26

%

Intesa Sanpaolo S.p.A.

   (Line 2)

 

 

3,587

 

 

 

4,292

 

 

April 2024

 

Euribor 3 months + 2.60%

 

 

 

2.06

%

 

 

2.06

%

Intesa Sanpaolo S.p.A.

   (Line 3)

 

 

9,384

 

 

 

9,688

 

 

June 2026

 

Euribor 3 months + 1.65%

 

 

 

1.11

%

 

 

1.11

%

Intesa Sanpaolo S.p.A.

   (Line 4)

 

 

6,523

 

 

 

6,734

 

 

July 2026

 

Euribor 3 months + 1.70%

 

 

 

1.16

%

 

 

1.16

%

UBI Banca S.p.A. (Line 1)

 

 

51

 

 

 

209

 

 

August 2021

 

Euribor 3 months + 1.25%

 

 

 

1.25

%

 

 

1.25

%

UBI Banca S.p.A. (Line 2)

 

 

401

 

 

 

1,031

 

 

October 2021

 

Euribor 3 months +1.95%

 

 

 

1.41

%

 

 

1.41

%

Monte dei Paschi di

   Siena S.p.A. (Line 1)

 

 

199

 

 

 

328

 

 

April 2022

 

 

0.95

%

 

 

0.95

%

 

 

0.95

%

Monte dei Paschi di

   Siena S.p.A. (Line 2)

 

 

1,579

 

 

 

2,037

 

 

June 2023

 

 

1.50

%

 

 

1.50

%

 

 

1.50

%

Banco BPM S.p.A. (Line 1)

 

 

824

 

 

 

1,056

 

 

June 2023

 

Euribor 3 months + 2.00%

 

 

 

2.00

%

 

 

2.00

%

Banco BPM S.p.A. (Line 3)

 

 

6,169

 

 

 

6,355

 

 

September 2024

 

Euribor 3 months + 3.00%

 

 

 

2.46

%

 

 

2.46

%

Simest 1

 

 

248

 

 

 

307

 

 

December 2023

 

 

0.50

%

 

 

0.50

%

 

 

0.50

%

Simest 2

 

 

246

 

 

 

305

 

 

December 2023

 

 

0.50

%

 

 

0.50

%

 

 

0.50

%

Simest 3

 

 

452

 

 

 

560

 

 

December 2023

 

 

0.50

%

 

 

0.50

%

 

 

0.50

%

Total bank and other borrowings

 

 

38,059

 

 

 

42,772

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less: current portion

 

 

9,448

 

 

 

10,798

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total long-term portion

 

$

28,611

 

 

$

31,974

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All bank and other borrowings are unsecured borrowings of Kaleyra.

On February 23, 2021, Kaleyra entered into an amendment to the existing unsecured loan agreement with Intesa Sanpaolo S.p.A. (the “Intesa Sanpaolo S.p.A. - Line 1”) and an amendment to the existing unsecured loan agreement with Intesa Sanpaolo S.p.A. (the “Intesa Sanpaolo S.p.A. - Line 2”). The amendments each provide that certain financial covenants be amended, in particular as they relate to the previously agreed net financial position/equity ratio and the net financial position/gross operating income ratio. Upon the approval of the audited statutory financial statements of Kaleyra S.p.A. for the year ended December 31, 2020 in June 2021, the calculated net financial position/gross operating income ratio failed to comply with the amended terms of the unsecured loan agreement with Intesa San Paolo S.p.A.. As a result of such failure, Intesa San Paolo S.p.A. was entitled to raise the interest rate bearing on the existing financing agreements of Intesa San Paolo S.p.A. by fifty (50) bps. No principal amount was subject to early reimbursement under the amended terms of the loan agreement. On August 3, 2021, the Company was notified by Intesa San Paolo S.p.A. of their resolution to apply the incremental fifty (50) bps to the interest rate bearing on future payments of interest.

On March 9, 2021 and March 10, 2021, respectively, Kaleyra S.p.A. received the approval by UniCredit to postpone repayment of the principal amounts due under the existing Line A Tranche (2), Line B and Line C of the long-term financing agreements with UniCredit S.p.A. for a period of six (6) months starting from March 1, 2021 until August 8, 2021, and under Line A Tranche (1) of the long-term financing agreement with UniCredit S.p.A. starting from February 1, 2021 until July 31, 2021. Consequently, the repayment schedule under all financing agreements mentioned above has been extended for the period equal to that of the six (6) month suspension period.

19


 

On April 15, 2021, Kaleyra S.p.A. and Banco Popolare di Milano S.p.A. entered into an agreement to postpone repayment of the principal amounts due under the existing Line 3 of the long-term unsecured financing agreement for a period of six (6) months starting from March 31, 2021 until September 30, 2021, without prejudice to Kaleyra S.p.A.’s obligations to continue to pay interest in relation to the principal amount at the original due dates.

On April 15, 2021, Kaleyra entered into a general unsecured loan agreement with Simest S.p.A for a total of $3.6 million (€3.0 million at the April 15, 2021 exchange rate) relating to the Fund 394/81 (the “Simest Financing”) and Fund for Integrated Promotion (the “Co-financing”) for implementation of a program to break into foreign markets. The principal amount of $505,000 (€422,000 at the April 15, 2021 exchange rate) of the financing applies to the Co-financing and has been granted in accordance with Section 3.1 of the Temporary Framework for State aid measures to support the economy in the current COVID-19 outbreak of the European Commission, and as such does not require repayment if used for the purposes stated within Fund 394/81.

The principal amount of $3.1 million (€2.6 million at the April 15, 2021 exchange rate) applies to the Simest Financing. The Simest Financing bears a subsidized interest rate of 0.055% and a reference interest rate of 0.55%. The loan will have a duration of six (6) years starting from the date of disbursement and will have to be repaid in half-yearly installments starting after a two-year pre-amortization period. As of June 30, 2021, the loan has not yet been disbursed pending the final documentation review by Simest S.p.A. under Fund 394/81 rules.

As of June 30, 2021, all of the available long-term facilities were drawn in full except for the Simest Financing as described above.

Interest expense on bank and other borrowings was $180,000 and $199,000 for the three months ended June 30, 2021 and 2020, respectively, and $370,000 and $417,000 for the six months ended June 30, 2021 and 2020, respectively.

As of June 30, 2021, the Company is obliged to make payments as follows (in thousands):

 

 

 

As of

June 30, 2021

 

2021 (remaining six months)

 

$

4,337

 

2022

 

 

10,957

 

2023

 

 

10,672

 

2024

 

 

6,240

 

2025

 

 

3,673

 

2026 and thereafter

 

 

2,180

 

Total

 

$

38,059

 

 

9. DEBT FOR FORWARD SHARE PURCHASE AGREEMENTS

As of June 30, 2021, the Company’s debt for forward share purchase agreements amounted to zero.

Yakira Capital Management (“Yakira”)

During the period from January 25, 2021 through March 2, 2021, Yakira provided notice to the Company that it sold all but 219 of the 43,930 shares that it held on December 31, 2020 in the open market at a price above $11.00 per share that were subject to the Third Yakira Amendment. On March 29, 2021, Yakira provided notice to the Company that it would not require the Company to purchase its remaining 219 shares by the term date of March 31, 2021. Following the sale of shares and the lapse of the Third Yakira Amendment mentioned above, the forward share purchase agreement with Yakira was terminated pursuant to its terms, and, as a result, the Company has no further obligations under the Yakira Purchase Agreement.

Nomura Global Financial Products

On February 25, 2021, in accordance with the terms of the agreement (the “Confirmation”) with Nomura Global Financial Products, Inc. (“NGFP”), NGFP fully terminated the forward share purchase agreement (“Forward Transaction”) and made a payment in the aggregate amount of $17.0 million to Kaleyra. Following the cash settlement of the Forward Transaction mentioned above, the Forward Transaction with NGFP has terminated pursuant to the terms of the Confirmation, and, as a result, the Company has no further obligations.

20


 

10. NOTES PAYABLE

Notes payable to the Sellers

As consideration for the Business Combination, on November 25, 2019 the Company issued unsecured convertible promissory notes to each of Esse Effe and Maya in the amount of $6.0 million and $1.5 million, respectively, (the “Business Combination Convertible Notes”) and also issued other unsecured promissory notes to each of Esse Effe and Maya in the identical respective amounts (the “Non-convertible Notes”). The Non-convertible Notes held by Esse Effe and Maya were paid in full during fiscal year 2020 and no amount remains outstanding for such notes as of June 30, 2021.

Business Combination Convertible Notes

As of June 30, 2021, the Business Combination Convertible Notes held by Esse Effe and Maya amounted to zero.

The Business Combination Convertible Notes are classified as “Notes payable due to related parties” in the accompanying condensed consolidated balance sheets. The accrued interest payable is included in “Other current liabilities” in the accompanying condensed consolidated balance sheets.

On the fifteen-month anniversary of the Business Combination Date or February 25, 2021, the fifty percent (50%) of the previously outstanding amount of Business Combination Convertible Notes held by Esse Effe and Maya was repaid, with a total of $3.0 million and $750,000 in principal and $176,000 and $44,000 in accrued interest being paid to Esse Effe and Maya, respectively, pursuant to the terms of the Business Combination Convertible Notes.

Under the terms of the Business Combination Convertible Notes, the outstanding principal balance of the Business Combination Convertible Notes, plus all accrued and unpaid interest and fees due under these notes, became due and payable, upon the receipt by the Company of cash proceeds of an equity financing in an aggregate gross amount of $105.0 million or 8,400,000 shares of Kaleyra common stock at $12.50 per share issued to the PIPE Investors in the private placement equity financing event immediately prior to the closing of the Merger Agreement of June 1, 2021. The principal amount of $3.8 million plus accrued interest of $84,000 for the Business Combination Convertible Notes held by Esse Effe and Maya was paid in full on June 2, 2021. Following the repayment, the Business Combination Convertible Notes terminated pursuant to their terms and no further amounts were due.

Notes payable - Other

On April 16, 2020, the Company entered into a Settlement Agreement and Release (the “Settlement Agreement”) with its Business Combination financial advisory service firms, Cowen and Company, LLC (“Cowen”) and Chardan Capital Markets, LLC, (“Chardan” and collectively the “Service Firms”), pursuant to which it agreed to pay an affiliate of Cowen, Cowen Investments II LLC (“Cowen Investments”), and Chardan, in full satisfaction of all amounts owed to the Service Firms as of December 31, 2019, $5.4 million in the aggregate, as follows: (i) $2.7 million in the aggregate in common stock of the Company (the “Settlement Shares”) to be issued the business day prior to the filing of a resale registration statement for such Settlement Shares (the “Bank Resale Registration Statement”), (ii) convertible notes totaling $2.7 million in the aggregate with a maturity date three years after issuance and bearing interest at five percent (5%) per annum (but with lower interest rates if the notes are repaid earlier than one year or two years after issuance) and with interest paid in arrears to the payee on March 15, June 15, September 15 and December 15 of each year, with such convertible notes to also be issued the business day prior to the filing of the Resale Registration Statement and (iii) in the event that the Beneficial Ownership Limitation (as defined below) would otherwise be exceeded upon delivery of the Settlement Shares above, a warrant agreement also to be entered into with and issued to the Services Firms the business day prior to the filing of the Resale Registration Statement, whereby the amount of common stock of the Company by which the Beneficial Ownership Limitation would otherwise have been exceeded upon delivery of the Settlement Shares will be substituted for by warrants with an exercise price of $0.01 per share issued pursuant to a Warrant Agreement (the “Warrant Agreement”) and the common stock underlying the Warrant Agreement (the “Warrant Shares”). The Beneficial Ownership Limitation shall initially be 4.99% of the number of shares of the common stock outstanding of the Company immediately after giving effect to the issuance of these shares of common stock. The number of Settlement Shares was calculated using as the price per Settlement Share an amount equal to a fifteen percent (15%) discount to the ten-day (10-day) trailing dollar volume-weighted average price for the common stock of the Company on the NYSE American LLC stock exchange (the “VWAP”) on the business day immediately prior to the date on which Kaleyra filed the Resale Registration Statement. In addition, the price per share for determining the number of shares of common stock of the Company to be issued upon the conversion of the convertible notes shall be a five percent (5%) premium to the ten-day (10-day) trailing VWAP as of the date immediately prior to the issuance date of the convertible notes, rounded down to the nearest whole number.

On May 1, 2020, in connection with the Settlement Agreement, the Company issued: (i) an aggregate of 440,595 Settlement Shares to Cowen Investments and Chardan, consisting of 374,506 Settlement Shares issued to Cowen Investments, and 66,089 Settlement Shares issued to Chardan, which resulted in a $0.2 million loss on settlement on the issuance date of May 1, 2020; and (ii) convertible promissory notes in the aggregate principal amount of $2.7 million to Cowen Investments and Chardan, consisting of a

21


 

convertible promissory note in the principal amount of $2.3 million issued to Cowen Investments (the “Cowen Note”) and a convertible promissory note in the principal amount of $405,000 issued to Chardan (the “Chardan Note”). The unpaid principal of the Cowen Note is convertible at the option of Cowen Investments into 303,171 shares of common stock of the Company, if there has been no principal reduction, and the unpaid principal of the Chardan Note is convertible at the option of Chardan into 53,501 shares of common stock of the Company, if there has been no principal reduction. As the Beneficial Ownership Limitation was not triggered by the issuance of the Settlement Shares, no Warrant Agreement was necessary and no warrants were issued.

As of December 31, 2020, the outstanding amount of the Cowen Note was $2.3 million and accrued interest was $63,000. As of December 31, 2020, the outstanding amount of the Chardan Note was $405,000 and accrued interest was $14,000.

On February 4, 2021, Cowen Investments elected to convert the outstanding amount of the Cowen Note into 303,171 shares of common stock pursuant to the terms of the Cowen Note, and as a result the Company has no further obligations with respect to the Cowen Note.

As of June 30, 2021, the outstanding amount of the Chardan Note was $405,000 and accrued interest was $24,000. This note payable is included in “Long-term portion of notes payable” and the accrued interest payable is included in “Other current liabilities” in the accompanying condensed consolidated balance sheets.

Merger Convertible Notes

On February 18, 2021, in support of the consummation of the Merger, Kaleyra entered into Convertible Note Subscription Agreements, each dated February 18, 2021, with the Convertible Note Investors. On June 1, 2021, the Company issued the Merger Convertible Notes with an aggregate principal amount of $200 million. The Company incurred $11.4 million of issuance costs as a result of the issuance of the Merger Convertible Notes.

In connection with the issuance of the Merger Convertible Notes pursuant to the terms of the Convertible Note Subscription Agreements, the Company entered into an indenture (the “Indenture”) with Wilmington Trust, National Association, a national banking association, in its capacity as trustee thereunder (the “Indenture Trustee”), in respect of the $200 million of Merger Convertible Notes that were issued to the Convertible Note Investors.

The Merger Convertible Notes bear interest at a rate of 6.125% per annum, payable semi-annually, in arrears on each June 1 and December 1 of each year, commencing on December 1, 2021, to holders of record at the close of business on the preceding May 15 and November 15, respectively. The Merger Convertible Notes are convertible into 11,851,852 shares of Parent Common Stock at a conversion price of $16.875 per share of Parent Common Stock in accordance with the terms of the Indenture, and mature five years after their issuance. The Company may, at its election, force conversion of the Merger Convertible Notes after (i) the first anniversary of the issuance of the Merger Convertible Notes, subject to a holder’s prior right to convert, if the last reported sale price of the Parent Common Stock exceeds 150% of the conversion price for at least 20 trading days during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter and (ii) the second anniversary of the issuance of the Merger Convertible Notes, subject to a holder’s prior right to convert, if the last reported sale price of the Parent Common Stock exceeds 130% of the conversion price for at least 20 trading days during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter. Following certain corporate events that occur prior to the maturity date or if the Company forces a mandatory conversion, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Merger Convertible Notes in connection with such a corporate event or has its Merger Convertible Notes mandatorily converted, as the case may be. In addition, in the event that a holder of the Merger Convertible Notes elects to convert its Merger Convertible Notes prior to the third anniversary of the issuance of the Merger Convertible Notes, the Company will be obligated to pay an amount equal to twelve months of interest, or if on or after such third anniversary of the issuance of the Merger Convertible Notes, any remaining amounts that would be owed to, but excluding, the fourth anniversary of the issuance of the Merger Convertible Notes (the “Interest Make-Whole Payment”). The Interest Make-Whole Payment will be payable in cash or shares of Parent Common Stock as set forth in the Indenture.

Upon the issuance of the Merger Convertible Notes, management made the assessment whether the convertible instrument contained embedded conversion features for bifurcation and concluded that such embedded conversion features met the definition of a derivative but qualified for the scope exception under ASC 815-10-15-74(a) as they are indexed to the Company’s stock and qualify for classification within stockholders’ equity. Management determined that the Interest Make-Whole Payment met the definition of a derivative, but the value was de minimis and as such no amount was recorded at the time of the issuance of the Merger Convertible Notes. Management will continue to monitor the valuation of the Interest Make-Whole Payment provision and assess the need to record a liability in future periods.

22


 

As of June 30, 2021, the outstanding amount of the Merger Convertible Notes was $188.8 million, net of issuance costs. During the one-month period following the issuance of the convertible notes accrued contractual interest and amortization of issuance costs amounted to $973,000 and $196,000, respectively. The liability is included in the condensed consolidated balance sheet line item “Long-term portion of notes payable” and the interest expense is included in “Finance expense, net” on the condensed consolidated statements of operations.

11. ACCUMULATED OTHER COMPREHENSIVE LOSS

The accumulated balances related to each component of accumulated other comprehensive loss are as follows (in thousands):

 

 

 

Cumulative

Foreign

Currency

Translation

Adjustment

 

 

Cumulative

Net Unrealized

Gain (Loss)

on Marketable

Securities,

Net of Tax

 

 

Accumulated

Other

Comprehensive

Income (Loss)

 

As of December 31, 2020

 

$

(2,836

)

 

$

10

 

 

$

(2,826

)

Other comprehensive income (loss), net of tax

 

 

1,105

 

 

 

(4

)

 

 

1,101

 

As of March 31, 2021

 

$

(1,731

)

 

$

6

 

 

$

(1,725

)

Other comprehensive income (loss), net of tax

 

 

(602

)

 

 

23

 

 

 

(579

)

As of June 30, 2021

 

$

(2,333

)

 

$

29

 

 

$

(2,304

)

 

 

 

Cumulative

Foreign

Currency

Translation

Adjustment

 

 

Cumulative

Net Unrealized

Gain (Loss)

on Marketable

Securities,

Net of Tax

 

 

Accumulated

Other

Comprehensive

Income (Loss)

 

As of December 31, 2019

 

$

78

 

 

$

(4

)

 

$

74

 

Other comprehensive income (loss), net of tax

 

 

(502

)

 

 

4

 

 

 

(498

)

As of March 31, 2020

 

$

(424

)

 

$

 

 

$

(424

)

Other comprehensive income (loss), net of tax

 

 

(691

)

 

 

 

 

 

(691

)

As of June 30, 2020

 

$

(1,115

)

 

$

 

 

$

(1,115

)

 

12. PREFERENCE SHARES LIABILITIES

Preference shares liabilities amounting to zero as of June 30, 2021 and December 31, 2020, represented the Company’s obligation to purchase in 2020 the preference shares from certain employees of Solutions Infini as a part of the Solutions Infini 2018 Purchase Agreement.

During fiscal year 2020, following the agreement with the eligible employees of the preference shares to pay performance bonuses for a total amount of $3.5 million, as a replacement of the preference shares obligation, the performance bonus obligation payable to the eligible employees was paid in two different installments of $1.4 million on August 31, 2020, and of $883,000 on November 30, 2020.

Following the full and final settlement agreements signed with the eligible employees on February 3, 2021, the previously outstanding performance bonus obligation of $1.2 million payable to the eligible employees under the Solutions Infini 2018 Purchase Agreement was paid in full by June 30, 2021 and as such the obligation terminated pursuant to its terms and no further obligation remains outstanding.

23


 

13. OTHER CURRENT AND LONG-TERM LIABILITIES

Other current liabilities consisted of the following (in thousands):

 

 

 

As of June 30,

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Liabilities for tax other than income tax

 

$

448

 

 

$

2,942

 

Social security liabilities

 

 

368

 

 

 

383

 

Current tax liabilities

 

 

894

 

 

 

434

 

Accrued financial interest

 

 

147

 

 

 

1,066

 

Capital leases

 

 

110

 

 

 

138

 

Accrued contractual interests

 

 

973

 

 

 

 

Other miscellaneous

 

 

3,707

 

 

 

1,025

 

Total other current liabilities

 

$

6,647

 

 

$

5,988

 

 

Other long-term liabilities consisted of the following (in thousands):

 

 

 

As of June 30,

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Interest rate swaps

 

$

66

 

 

$

109

 

Warrant liability

 

 

1,155

 

 

 

 

Capital leases

 

 

162

 

 

 

208

 

Other miscellaneous

 

 

284

 

 

 

286

 

Total other long-term liabilities

 

$

1,667

 

 

$

603

 

 

14. GEOGRAPHIC INFORMATION

Revenue by geographic area is determined on the basis of the location of the customer, unless the delivery location is triggered by concentration criteria. The Company generates its revenue primarily in Italy, India and the United States. The following table sets forth revenue by geographic area for the three and six months ended June 30, 2021 and 2020 (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Italy

 

$

19,164

 

 

$

13,547

 

 

$

35,251

 

 

$

28,155

 

India

 

 

13,595

 

 

 

6,224

 

 

 

25,313

 

 

 

15,117

 

United States

 

 

10,971

 

 

 

6,353

 

 

 

16,092

 

 

 

10,642

 

Europe (excluding Italy)

 

 

1,839

 

 

 

2,574

 

 

 

3,257

 

 

 

5,147

 

South America

 

 

2,452

 

 

 

 

 

 

2,452

 

 

 

 

Rest of the world

 

 

5,971

 

 

 

2,501

 

 

 

11,341

 

 

 

5,771

 

Total

 

$

53,992

 

 

$

31,199

 

 

$

93,706

 

 

$

64,832

 

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Italy

 

 

35.5

%

 

 

43.4

%

 

 

37.6

%

 

 

43.4

%

India

 

 

25.2

%

 

 

19.9

%

 

 

27.0

%

 

 

23.4

%

United States

 

 

20.3

%

 

 

20.4

%

 

 

17.2

%

 

 

16.4

%

Europe (excluding Italy)

 

 

3.4

%

 

 

8.3

%

 

 

3.5

%

 

 

7.9

%

South America

 

 

4.5

%

 

 

0.0

%

 

 

2.6

%

 

 

0.0

%

Rest of the world

 

 

11.1

%

 

 

8.0

%

 

 

12.1

%

 

 

8.9

%

 

24


 

 

As of June 30, 2021, the majority of the Company’s long-lived assets are located in Italy, India and the United States. The following table sets forth long-lived assets by geographic area as of June 30, 2021 and December 31, 2020 (in thousands):

 

 

 

As of June 30,

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Italy

 

$

3,486

 

 

$

2,827

 

India

 

 

2,512

 

 

 

1,667

 

United States

 

 

9,134

 

 

 

2,225

 

Rest of the world

 

 

807

 

 

 

7

 

Total

 

$

15,939

 

 

$

6,726

 

 

 

 

As of June 30,

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

Italy

 

 

21.9

%

 

 

42.0

%

India

 

 

15.7

%

 

 

24.8

%

United States

 

 

57.3

%

 

 

33.1

%

Rest of the world

 

 

5.1

%

 

 

0.1

%

 

15. COMMITMENTS AND CONTINGENCIES

Lease Commitments

The Company entered into various operating lease agreements that expire over various years in the next 7 years. The Company’s Milan office lease contains an option to renew the lease for 6 years under terms and conditions set forth in the lease agreement. Certain of the Company’s leases contain provisions for rental adjustments. Operating lease rentals are expensed on a straight-line basis over the life of the lease beginning on the date the Company takes possession of the property. Rent expense was $249,000 and $206,000 for the three months ended June 30, 2021 and 2020, respectively, and $441,000 and $441,000 for the six months ended June 30, 2021 and 2020, respectively.

Future minimum lease payments under leasing obligations as of June 30, 2021 are as follows (in thousands):

 

 

 

As of June 30, 2021

 

 

 

Operating Leases

 

 

Capital Leases

 

 

Total

 

2021 (remaining six months)

 

$

720

 

 

$

73

 

 

$

793

 

2022

 

 

1,296

 

 

 

76

 

 

 

1,372

 

2023

 

 

669

 

 

 

62

 

 

 

731

 

2024

 

 

560

 

 

 

62

 

 

 

622

 

2025

 

 

365

 

 

 

18

 

 

 

383

 

2026 and thereafter

 

 

132

 

 

 

 

 

 

132

 

Total minimum lease payments

 

$

3,742

 

 

$

291

 

 

$

4,033

 

 

Future minimum lease payment under capital leases as of June 30, 2021, consisted of the following (in thousands):

 

 

 

As of June 30, 2021

 

 

 

Capital Leases

 

Total payments

 

$

291

 

Less: interest portion

 

 

19

 

Net capital lease obligation

 

 

272

 

Less: current portion

 

 

110

 

Long term portion

 

$

162

 

The current and long term portion of the future minimum lease payments under capital lease are included in the condensed consolidated balance sheet line item “Other current liabilities” and “Other long-term liabilities”, respectively.

25


 

Contingencies

As of June 30, 2021, the Company had contingent liabilities of $127,000, relating to a tax appeal of Solutions Infini for which no provision was recognized as its occurrence was deemed remote.

16. RESTRICTED STOCK UNITS (RSUs)

The following table sets forth the activity related to the number of outstanding RSUs for the six months ended June 30, 2021:

 

 

 

Number of

shares

 

 

Weighted-

average

grant date

fair value

(per share)

 

Non-vested as of December 31, 2020

 

 

3,331,037

 

 

$

7.48

 

Vested

 

 

(935,115

)

 

 

8.67

 

Granted

 

 

1,094,150

 

 

 

15.57

 

Cancelled

 

 

(23,463

)

 

 

9.84

 

Non-vested as of June 30, 2021

 

 

3,466,609

 

 

$

9.70

 

 

RSUs compensation expense for the three and six months ended June 30, 2021 was $4.7 million and $9.3 million, respectively, which was recorded as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Research and development

 

$

806

 

 

$

1,140

 

 

$

1,777

 

 

$

2,452

 

Sales and marketing

 

 

866

 

 

 

1,100

 

 

 

1,388

 

 

 

2,153

 

General and administrative

 

 

3,038

 

 

 

2,390

 

 

 

6,105

 

 

 

6,229

 

Total

 

$

4,710

 

 

$

4,630

 

 

$

9,270

 

 

$

10,834

 

As of June 30, 2021, there was $20.1 million of unrecognized compensation cost related to non-vested RSUs to be recognized over a weighted-average remaining period of 1.51 years.

17. INCOME TAXES

The Company provides for income taxes using an asset and liability approach under which deferred income taxes are provided for based upon enacted tax laws and rates applicable to periods in which the taxes become payable.

The Company recorded an income tax benefit of $7.4 million and $313,000 for the three months ended June 30, 2021 and 2020, respectively, and an income tax benefit of $7.4 million and $902,000 for the six months ended June 30, 2021 and 2020, respectively.

The Company continues to maintain a valuation allowance against its domestic deferred tax assets, with the exception of certain deferred tax liabilities as result of purchase accounting adjustments, and most foreign jurisdictions other than India also maintain a valuation allowance against its deferred tax assets. On March 27, 2020, the United States enacted the CARES Act in response to the COVID-19 pandemic. The CARES Act, among other things, permits net operating loss carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act allows net operating loss incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The Company recognized a $959,000 discrete tax benefit during the three months ending June 30, 2021, related to a release of the domestic valuation allowance associated with a net operating loss carryback.

During the three months ended June 30, 2021, the Company also released $5.8 million in valuation allowance related to previously reserved deferred tax assets which the Company has determined will be utilized in the future to offset net deferred tax liabilities related to the mGage acquisition during the period.

As of June 30, 2021, the Company maintained $5.3 million of undistributed earnings and profits generated by a foreign subsidiary (Solutions Infini) for which no deferred tax liabilities have been recorded, since the Company intends to indefinitely reinvest such earnings in the subsidiary to fund the international operations and certain obligations of the subsidiary. Should the above undistributed earnings be distributed in the form of dividends or otherwise, the distributions would result in approximately $787,000 of tax expense.

26


 

The Company files income tax returns in the United States and in foreign jurisdictions including Italy, India, and Switzerland. As of June 30, 2021, the tax years 2008 through the current period remain open to examination in each of the major jurisdictions in which the Company is subject to tax.

18. WARRANTS

Warrants will only be exercisable for whole shares at $11.50 per share. Under the terms of the warrant agreement dated December 12, 2017 (the “Warrant Agreement”), the Company has agreed to use its best efforts to file a new registration statement following the completion of the Business Combination, for the registration of the shares of common stock issuable upon exercise of the warrants. That registration statement was filed by the Company on May 4, 2020 and declared effective by the SEC on May 8, 2020. No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number for the number of shares of common stock to be issued to the warrant holder. Each warrant became exercisable 30 days after the completion of the Business Combination and will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation. Once the warrants became exercisable, the Company may redeem the outstanding warrants in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Company’s shares of common stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the warrant holders.

On April 12, 2021, the SEC issued a SEC Staff Statement on “Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”) (the “SEC Staff Statement”). The SEC Staff Statement addresses certain accounting and reporting considerations related to warrants of a kind similar to those issued by the Company at the time of its initial public offering in December 2019. Based on ASC 815-40, “Contracts in Entity’s Own Equity”, warrant instruments that do not meet the criteria to be considered indexed to an entity’s own stock shall be initially classified as liabilities at their estimated fair values. In periods subsequent to issuance, changes in the estimated fair value of the derivative instruments should be reported in the consolidated statements of operations. Following the SEC Staff Statement, management evaluated the fact pattern set forth within Kaleyra’s Warrant Agreement and concluded that the warrants issued in connection with private placements that occurred in December 2017 and January 2018 concurrently with its initial public offering (the “Private Placement Warrants”) should have been recorded as a liability at fair value as the Private Placement Warrants were not considered to be indexed to the entity’s own stock. Because the transfer of Private Placement Warrants to anyone other than the initial purchasers or their permitted transferees would result in the Private Placement Warrants having substantially the same terms as warrants issued in the Company’s initial public offering, management determined that the fair value of each Private Placement Warrant approximates the fair value of its publicly traded warrants.

Management analyzed the impact of this error on the Company’s prior consolidated financial statements beginning from the date when the Private Placement Warrants were issued and concluded that the adjustments were immaterial to any period presented in previously issued consolidated financial statements. The out-of-period adjustment related to the prior periods was also immaterial to the three months ended March 31, 2021. As a result of this analysis, the Company corrected this error in the three months ended March 31, 2021.

The correction resulted in an increase of $534,000 in other long-term liabilities, a decrease of $344,000 in additional paid-in capital and an increase of $190,000 in financial income (expense), net for the quarter ended March 31, 2021.

During the three months ended June 30, 2021, the Company recorded $433,000 in “Financial expense, net” on the condensed consolidated statement of operation for the change in fair value of the Private Placement Warrants. During the six months ended June 30, 2021, the Company recorded $830,000, including the $190,000 attributable to prior periods, in “Financial expense, net” on the condensed consolidated statements of operations for the change in fair value of the Private Placement Warrants.

As of June 30, 2021, there were 7,125,232 warrants outstanding.

19. NET LOSS PER SHARE

The following table sets forth the calculation of basic and diluted net loss per share during the period presented (in thousands, except share and per share data):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net loss

 

$

(4,487

)

 

$

(8,128

)

 

$

(14,845

)

 

$

(16,951

)

Weighted average shares used to compute net loss per common share, basic and diluted

 

 

34,292,874

 

 

 

20,606,816

 

 

 

32,328,909

 

 

 

20,293,203

 

Net loss per common share, basic and diluted

 

$

(0.13

)

 

$

(0.39

)

 

$

(0.46

)

 

$

(0.84

)

27


 

 

 

The Company generated a net loss for each of the three and six months ended June 30, 2021 and 2020. Accordingly, the effect of dilutive securities is not considered in the net loss per share for such periods because their effect would be anti-dilutive on the net loss per share.

For the three and six months ended June 30, 2021, the weighted-average number of outstanding shares of common stock equivalents, which were excluded from the calculation of the diluted net loss per share as their effect would be anti-dilutive, was 10,653,658 and 11,679,120, respectively (16,881,691 and 17,377,360 for the three and six months ended June 30, 2020, respectively).

20. TRANSACTIONS WITH RELATED PARTIES

During the three and six months ended June 30, 2021 and 2020, related party transactions, other than compensation and similar arrangements in the ordinary course of business, were as follows:

 

i.

Unsecured convertible promissory notes, received by Esse Effe and Maya at the closing of the Business Combination, pursuant to the terms of the Stock Purchase Agreement. Maya is affiliated with Dario Calogero and the shares are beneficially owned by a shareholder, Mr. Calogero, who is the Chief Executive Officer and a director of Kaleyra. Esse Effe is affiliated with Dr. Emilio Hirsch, and its shares are beneficially owned by Dr. Hirsch, a shareholder and a director of the Company. Under the terms of the unsecured convertible promissory notes, the previously outstanding principal balance of these notes, plus all accrued and unpaid interest, became due and payable following the private placement equity financing event in support for the consummation of the Merger Agreement for the acquisition of mGage of June 1, 2021. The outstanding principal amount of $3.8 million plus accrued interest of $84,000 was paid in full on June 2, 2021 and the obligation terminated pursuant to its terms. No outstanding amount was due by the Company as of June 30, 2021 ($7.5 million plus $241,000 of accrued interest as of December 31, 2020). See Note 10 – Notes Payable – for additional information;

 

ii.

Legal services rendered by a partner of Studio Legale Chiomenti, a family member of a key manager of the Company. Costs incurred by the Company for the above services were zero and $80,000 in the three and six months ended June 30, 2021, respectively ($86,000 and $142,000 in the three and six months ended June 30, 2020, respectively);

 

iii.

Alessandra Levy, the spouse of Kaleyra’s Chief Executive Officer, Dario Calogero, is an employee within the marketing team of Kaleyra S.p.A.. Ms. Levy received salary and benefits in the amount of $63,000 and $124,000 for the three and six months ended June 30, 2021, respectively ($58,000 and $116,000 in the three and six months ended June 30, 2020, respectively);

 

iv.

Pietro Calogero, the son of Kaleyra’s Chief Executive Officer, Dario Calogero, is an employee within the research and development team of Kaleyra S.p.A.. Mr. Pietro Calogero received salary and benefits in the amount of $13,000 and $24,000 for the three and six months ended June 30, 2021, respectively ($7,000 and $12,000 in the three and six months ended June 30, 2020, respectively); and

 

v.

As mentioned in Note 12, in the three months ended March 31, 2020, as a result of the modification of the Solutions Infini 2018 Purchase Agreement, a significant portion of the liability for preference shares was replaced with bonus compensation of $3.5 million. During fiscal year 2020, the previously outstanding bonus compensation payable to executive managers was paid in two different installments of $1.4 million on August 31, 2020, and of $883,000 on November 30, 2020. Following the full and final settlement agreements signed on February 3, 2021, the previously outstanding performance bonus obligation of $1.2 million payable to the eligible employees under the Solutions Infini 2018 Purchase Agreement was paid in full by June 30, 2021 and as such the obligation terminated pursuant to its terms and no further obligation remains outstanding as of June 30, 2021. See Note 12 – Preference Shares Liabilities – for further details.

The following table presents the expenses for transactions with related parties reported in the condensed consolidated statements of operations (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Research and development

 

$

13

 

 

$

7

 

 

$

25

 

 

$

12

 

Sales and marketing

 

 

63

 

 

 

58

 

 

 

123

 

 

 

115

 

General and administrative

 

 

 

 

 

86

 

 

 

80

 

 

 

142

 

Financial expense, net

 

 

19

 

 

 

122

 

 

 

63

 

 

 

244

 

 

28


 

 

21. REVENUE

Revenue Recognition

The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of allowances for credits and any taxes collected from customers. Taxes collected are subsequently remitted to governmental authorities.

The Company determines revenue recognition through the following steps:

• Identification of the contract, or contracts, with a customer;

• Identification of the performance obligations in the contract;

• Determination of the transaction price;

• Allocation of the transaction price to the performance obligations in the contract; and

• Recognition of revenue when, or as, the Company satisfies a performance obligation.

Nature of Products and Services

The Company's revenue is primarily derived from usage-based fees earned from the sale of communications services offered through software solutions mainly to large enterprises and medium-sized customers.

The Company’s revenue is recognized upon the sending of a message, the execution of a voice call, the usage of microservices available in-platform, or by the authentication of a financial transaction of an end user of the Company’s customer using the Company’s platform in an amount that reflects the consideration the Company expects to receive in exchange for those services which is generally based upon agreed fixed prices per unit.

Platform access is considered a monthly service comprised of one performance obligation and usage-based fees are recognized as revenue in the period in which the usage occurs. After usage occurs, there are no remaining obligations that would preclude revenue recognition. Revenue from usage-based fees represented 96% and 97% of total revenue, for the three and the six months ended June 30, 2021, respectively (98% and 98% of total revenue for the three and six months ended June 30, 2020, respectively).

Subscription-based fees are derived from certain term-based contracts, such as with the sales of short codes, usage of Whatsapp®, and customer support, which are generally at least one year long. Term-based contract revenue is recognized on a ratable basis over the contractual term of the arrangement beginning on the date that the service is made available to the customer. Revenue from term-based fees represented 4% and 3% of total revenue for the three and the six months ended June 30, 2021, respectively (2% and 2% of total revenue for the three and six months ended June 30, 2020, respectively).

The Company's arrangements do not contain general rights of return. The contracts do not provide customers with the right to take possession of the software supporting the applications. Amounts that have been invoiced are recorded in trade receivables and in revenue or deferred revenue depending on whether the revenue recognition criteria have been met.

Contract Balances

The Company receives payments from customers based on a billing schedule as established in its contracts. Contract assets are recorded when the Company has a conditional right to consideration for its completed performance under the contracts. Trade receivables are recorded when the right to this consideration becomes unconditional, which is as usage occurs. The Company did not have any contract assets as of June 30, 2021 and December 31, 2020.

Deferred revenue is recorded when cash payments are received in advance of future usage on non-cancellable contracts. As of June 30, 2021 and December 31, 2020, the Company recorded $10.8 million and $3.7 million, respectively, as deferred revenue in its condensed consolidated balance sheets. In the three and six months ended June 30, 2021, the Company recognized $559,000 and $2.2 million, respectively, of revenue in its condensed consolidated statements of operations that was included in deferred revenue as of December 31, 2020.

Disaggregated Revenue

In general, revenue disaggregated by geography is aligned according to the nature and economic characteristics of the Company’s business and provides meaningful disaggregation of the Company’s results of operations. See Note 14 – Geographic Information for details of revenue by geographic area.

29


 

22. SUBSEQUENT EVENTS

On July 1, 2021, Kaleyra completed the company reorganization of the acquired business of mGage through the initial dissolution of the Delaware single member LLCs of Vivial Holdings, LLC, Vivial Networks, LLC, and the following merger of mGage, LLC into the surviving holding company, Vivial Inc., that changed its name into Kaleyra US Inc. as a result of the reorganization. After the merger, Kaleyra US Inc. would be the holding company of the following entities: one hundred percent (100%) direct ownership of mGage Europe Ltd. (UK) and one hundred percent (100%) direct ownership of mGage SA de SV (Mexico).

On July 8, 2021, Kaleyra announced the acquisition of Bandyer for a price consideration of $15.5 million. Bandyer offers cloud-based audio/video communications services via WebRTC technology to financial institutions, retail companies, utilities, industries, insurance, human resources and digital healthcare organizations. Bandyer has been serving customers with programmable audio/video APIs and SDKs based on WebRTC technology for a variety of use cases including group video calls and webinars.

30


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following management’s discussion and analysis in conjunction with the condensed consolidated financial statements of Kaleyra, Inc. (“Kaleyra,” the “Company,” “we,” “us,” and “our” refer to Kaleyra, Inc. and all of its consolidated subsidiaries) and the related notes included elsewhere in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2021. The discussion below includes forward-looking statements about Kaleyra’s business, operations and industry that are based on current expectations that are subject to uncertainties and unknown or changed circumstances. Kaleyra’s actual results may differ materially from these expectations as a result of many factors, including, but not limited to, those risks and uncertainties described under “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2020 and this Quarterly Report on Form 10-Q. We assume no obligation to update the forward-looking statements or such risk factors.

This Quarterly Report on Form 10-Q and the documents incorporated herein by reference include forward‑looking statements within the meaning and protections of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements are also made in reliance upon the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements with respect to Kaleyra’s beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements.

Overview

On November 25, 2019, the Company (f/k/a GigCapital, Inc.) completed the acquisition of Kaleyra S.p.A., pursuant to the terms of a Stock Purchase Agreement (the “Business Combination”). In connection with the Closing, the Company changed its name from GigCapital, Inc. to Kaleyra, Inc. GigCapital, Inc. was incorporated in Delaware on October 9, 2017 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Kaleyra S.p.A. is a cloud communications software provider delivering secure Application Protocol Interfaces (“APIs”) and connectivity solutions in the API/Communication Platform as a Service market (“CPaaS”), headquartered in Milan, Italy and with operations in Italy, India, Dubai and the United States.

Kaleyra S.p.A. is a result of the expansion of the former Ubiquity, which was founded in Milan, Italy in 1999.

After securing a leading market position in mobile messaging in the Italian financial services industry, Kaleyra S.p.A. sought to expand its products and geographic offerings. Ubiquity acquired Solutions Infini in Bangalore, India beginning in 2017 and Buc Mobile in Vienna, Virginia in 2018. It was rebranded Kaleyra S.p.A. in February 2018.

On April 23, 2020, Kaleyra strengthened its commitment to delivering solutions for the financial services industry with the launch by Buc Mobile of k-lab, a dedicated innovation lab for new product development to support enterprise mobile communications. This innovation lab is the center of excellence dedicated to supporting Kaleyra in developing new solutions to enhance customer experiences, and in particular, for the financial service companies to be served by Kaleyra in the U.S. markets.

On July 29, 2020, Kaleyra registered a German branch of Kaleyra S.p.A. with the German Chamber Tax Authority of Commerce. Kaleyra established its branch in Germany, by far the most important country in Europe to Kaleyra after Italy, to expand Kaleyra’s footprint in Central Europe and the Nordic countries and allow it to leverage Kaleyra’s trusted business solutions for customers in additional jurisdictions.

Kaleyra’s subsidiary, Campaign Registry Inc., a systems initiative to reduce spam by collecting robotically driven campaign information and processing and sharing that information with mobile operators and the messaging ecosystem, began its soft launch during the second quarter of fiscal year 2020 and obtained its first revenue contracts in the second half of 2020.

On February 18, 2021, Kaleyra executed the Merger Agreement for the acquisition of the business known as mGage, a leading global mobile messaging provider. On June 1, 2021, Kaleyra acquired mGage for a total purchase price of $218.0 million. The Merger consideration consisted of both cash consideration and common stock consideration. The cash consideration amounted to $199.2 million of which $198.6 million was paid on June 1, 2021 and the remaining amount is expected to be settled in fiscal 2021. The common stock consideration was paid with the issuance to Vivial’s former equity holders of a total of 1,600,000 shares of Kaleyra common stock at the $11.77 per share closing price of Kaleyra common stock on the date of issuance, equal to $18.8 million. In support of the consummation of the Merger, on February 18, 2021, Kaleyra entered into the PIPE Subscription Agreements with the PIPE Investors, pursuant to which, among other things, Kaleyra agreed to issue and sell, in private placements to close immediately prior to the closing of the Merger, an aggregate of 8,400,000 shares of Kaleyra common stock to the PIPE Investors at $12.50 per share, and Kaleyra also entered into the Convertible Note Subscription Agreements with the Convertible Note Investors, pursuant to

31


 

which Kaleyra agreed to issue and sell, in private placements to close immediately prior to the closing of the Merger, $200 million aggregate principal amount of unsecured Merger Convertible Notes.

Kaleyra provides its customers and business partners with a trusted cloud communications platform (the “Platform”) that seamlessly integrates software services and applications for business-to-consumer communications between Kaleyra’s customers and their end-user customers and partners on a global basis. These communications are mostly managed through mobile network operators as the gateway to reach end-user consumers’ mobile devices. Kaleyra’s Platform enables these communications by integrating mobile alert notifications and interactive capabilities to reach and engage end user customers. It does so, coupled with a “software as a service” (SaaS) business model, creating what is generally referred to as a “cloud communications platform as a service”, or simply CPaaS. Kaleyra’s solutions include identity authentication, mobile and voice notifications on transactions, and banking services authorizations, most notably via different integrated mobile channels through its Platform.

Kaleyra’s vision is to be the CPaaS provider which best aligns with its customers’ communication requirements and the most trusted provider in the world. This requires a combination of security, compliance and integration capabilities that protects the integrity and privacy of Kaleyra’s customers’ and business partners’ transactions and includes other key features such as ease of provisioning, reliable network connectivity, high availability for scaling, redundancy, embedded regulatory compliance, configurable monitoring and reporting. Kaleyra believes the percentage of CPaaS customers that will require security, compliance and integration will represent an increasingly larger portion of the market, particularly with the expected exponential growth of transactional-by-nature cloud communications applications, better enabling Kaleyra to set itself apart from its competition.

During the three and six months ended June 30, 2021, Kaleyra processed nearly 8.5 billion and 15.5 billion billable messages and 1.4 billion and 2.6 billion voice calls, respectively. Kaleyra organizes its efforts in four regions, Americas, Europe, APAC and MEA. Its workforce is spread across the globe either in full-remote or office-based mode, in one of its principal offices based in New York, New York, Vienna, Virginia, Los Angeles, California, Atlanta, Georgia, Milan, Italy, Munich, Germany, London, United Kingdom, Bangalore, India. Kaleyra’s employee base is over 510 employees, following the closing of the Merger.

Kaleyra has more than 3,800 customers and business partners worldwide across industry verticals such as financial services, ecommerce and transportation. In the three months ended June 30, 2021 and 2020, Kaleyra had zero and one customer which accounted for more than 10% of Kaleyra’s revenues, respectively. In the six months ended June 30, 2021 and 2020, Kaleyra had zero customer in both periods which accounted for more than 10% of Kaleyra’s revenues. Kaleyra has multiple large European commercial banks as business partners, with one of these partners, Intesa Sanpaolo S.p.A., accounting for more than 10% of Kaleyra’s business volume in both the three and six months ended June 30, 2021 and 2020.

For the three and six months ended June 30, 2020, 75.1% and 81.0% of revenues, respectively, came from customers which have been on the platform for at least one year. Although Kaleyra continues to expand by introducing new customers to the platform, the breadth and stability of its existing customers provide it with a solid base of revenue upon which it can continue to innovate and make investment to strengthen its product portfolio, expand its global presence, recruit world-class talent and target accretive acquisitions to capitalize on its growing market penetration opportunities and value creation.

Kaleyra’s underlying technology used in the Platform is the same across all of its communication services which can generally be described as “omni-channel mobile first interactive notifications via a public or private cloud implementation.” These services include programmable voice/Interactive Voice Response (IVR) configurations, inbound/outbound short message service capabilities, hosted telephone numbers, and other types of IP communications services such as e-mail and WhatsApp®.

Kaleyra’s key customers are large Business to Consumer (“B2C”) and Business to Business to Consumer (“B2B2C”) enterprises which use digital, mobile communications in the conduct of their business. Kaleyra’s Platform enables these communications by integrating mobile alert notifications and interactive capabilities to reach and engage end-user customers. Kaleyra enables its customers and business partners to connect enterprise software and applications to mobile network operators. Also, Kaleyra provides simple interfaces and APIs for multiple channels and continuously updates its product offering to account for new end-user consumer behavior changes and progresses.

Kaleyra services a broad base of customers throughout the world operating in diverse businesses and regions. Kaleyra’s business is generated by providing data to the telecommunications provider and transmitting message data from its customers or business partners. Kaleyra has a concentration of business within the financial services industry that serves their major European banking end-user customers. With each relationship Kaleyra is the link between the financial institutions and their unique, end-user customers. In linking these two parties, Kaleyra’s Platform leverages the telecommunications provider to transmit critical message data to these end-user customers.

For the three and six months ended June 30, 2021 and 2020, the majority of Kaleyra’s revenue was derived from its multi-channel CPaaS product offering market.

Kaleyra’s revenue is primarily driven by the number of messages delivered and voice calls connected to its customers and business partners. Kaleyra’s fees vary depending on the contract. In the three months ended June 30, 2021, the number of messages delivered to customers increased by 61.8%, compared to the three months ended June 30, 2020, and the number of voice calls

32


 

connected to customers increased by 194.8%, compared to the three months ended June 30, 2020. In the six months ended June 30, 2021, the number of messages delivered to customers increased by 27.9%, compared to the six months ended June 30, 2020, and the number of voice calls connected to customers increased by 106.3%, compared to the six months ended June 30, 2020. The increase in the number of messages delivered to customers is mainly driven by the volume additions following the business combination with mGage. The increase in voice calls connected to its customers was mainly the result of higher voice activities in India, as compared to the same period of prior year. The number of messages delivered and voice calls connected to customers is still affected by the spread of the COVID-19 pandemic, including the most recent surge in the Delta variant strain, which resulted in significant fluctuations in Kaleyra’s services carrying less revenue-generating traffic in areas subject to “shelter in place” restrictions or related government orders.

Kaleyra’s business partners in Italy mainly consist of banks and other credit card issuers that connect to their customers (end-user customers) sending highly secured and reliable messages through Kaleyra’s platform.

Volume increase has been driven by the increased number of digital payments transactions made by the end-user customers (such as credit card transactions and other digital payments), by the increasing usage of mobile banking features, and by the increasing penetration rate of digital payments in the underlying payments markets. Kaleyra is exposed to fluctuations of the currencies in which its transactions are denominated. Specifically, a material portion of Kaleyra’s revenues and purchases are denominated in Euro, Indian Rupees and United Arab Emirates Dirham.

FACTORS AFFECTING COMPARABILITY OF RESULTS

The business combination with mGage

On June 1, 2021, Kaleyra completed its Merger with Vivial, and the resulting acquisition of the business owned by Vivial known as mGage, a leading global mobile messaging provider. The acquisition of mGage provided an opportunity for Kaleyra to expand its network operator connections and become one of only four companies providing direct connectivity to all US carriers.

The purchase consideration amounting to $218.0 million consisted of cash consideration and common stock consideration. Cash consideration amounted to $199.2 million of which $198.6 million was paid on June 1, 2021 and the remaining amount is expected to be settled in fiscal 2021. The common stock consideration was paid with the issuance to Vivial’s former equity holders of a total of 1,600,000 shares of Kaleyra common stock. The resulting amount, which was based upon the $11.77 per share closing price of Kaleyra common stock as of June 1, 2021, was equal to $18.8 million and has been recognized as part of the consideration transferred.

mGage contributed $10.2 million to the consolidated total revenues for the month that it was consolidated in 2021 and represented 18.8% and 10.8% of the consolidated revenues for the three and six months ended June 30, 2021, respectively.

In 2021, the Company incurred costs related to the acquisition of mGage of $5.5 million that were expensed in General and Administrative expenses in the consolidated statement of operations.

COVID-19

The current COVID-19 pandemic has affected and will continue to affect economies and business around the world. To date, various governmental authorities and private enterprises have implemented numerous measures to contain the pandemic, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns, which have led to severe disruptions to the global economies that may continue for a prolonged duration and trigger a recession or a period of economic slowdown. The magnitude and duration of the resulting decline in business activity and operations cannot be measured with any degree of certainty. Indeed, during the pandemic, Kaleyra experienced fluctuations in its services carrying less revenue-generating traffic in areas subject to “shelter in place” restrictions or related government orders. Nonetheless, in the three and six months ended June 30, 2021, Kaleyra accounted for increasing revenues when compared to the same period of prior year, despite a negative impact in terms of gross marginality. At this stage, the extent and duration of the pandemic, and its foreseeable unfolding following the worldwide vaccine campaigns, is still uncertain and difficult to predict, also considering the severity of the second wave of the COVID-19 pandemic currently hitting the Indian regions and the most recent surge in the Delta variant strain. Kaleyra is actively monitoring and managing its response and assessing actual and potential impacts to its operating results and financial condition, which could also impact trends and expectations.

Critical Accounting Policies and Management Estimates

Our critical accounting policies and significant estimates are detailed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020. Our critical accounting policies and significant estimates have not changed substantially from those previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020, except as below. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment due to the recent outbreak of a novel strain of the coronavirus (“COVID-19”).

33


 

Warrant Liability

The Company accounts for warrants for shares of the Company’s common stock that are not indexed to its own stock as liabilities at fair value on the condensed consolidated balance sheets. The warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized in “Financial expense, net” on the condensed consolidated statements of operations. The liability is included in the condensed consolidated balance sheet line item “Other long-term liabilities”. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the common stock warrants. At that time, the portion of the warrant liability related to the common stock warrants will be reclassified to additional paid-in capital.

Key Business Metrics

Revenue

Kaleyra’s revenue is generated primarily from usage-based fees earned from the sale of communication services offered through software solutions mainly to large enterprises and medium-sized customers. Revenue can be billed in advance or in arrears depending on the terms of the agreement; for the majority of customers, revenue is invoiced on a monthly basis in arrears.

Cost of Revenue and Gross Profit

Cost of revenue consists primarily of costs of communications services purchased from network service providers. Cost of revenue also includes the cost of Kaleyra’s cloud infrastructure and technology platform, amortization of capitalized internal-use software development costs related to the platform applications and amortization of developed technology acquired in past business combinations.

Gross profit is equal to the revenue less cost of revenue associated with delivering the communication services to Kaleyra’s customers.

Operating Expenses

Kaleyra’s operating expenses include research and development expense, sales and marketing expense, general and administrative expense, transactions costs and depreciation and amortization, excluding the depreciation and amortization expense related to the technology platform.

Research and Development Expense

Research and development expense consist primarily of personnel costs, including stock-based compensation, the costs of the technology platform used for staging and development, outsourced engineering services, amortization of capitalized internal-use software development costs (other than those related to the technology platform) and an allocation of general overhead expenses. Kaleyra capitalizes the portion of its software development costs that meet the criteria for capitalization.

Sales and Marketing Expense

Sales and marketing expense is comprised of compensation, variable incentive compensation, benefits related to Kaleyra’s sales personnel, along with travel expenses, other employee related costs including stock-based compensation, and expenses related to advertising, marketing campaigns and events.

General and Administrative Expense

General and administrative expense is comprised of compensation and benefits of administrative personnel, including variable incentive pay and stock-based compensation, and other administrative costs such as facilities expenses, professional fees, and travel expenses.

34


 

Results of Operations

Comparison of the three months ended June 30, 2021 and 2020

 

 

 

Three Months Ended June 30,

 

 

 

 

 

 

2021

 

 

2020

 

 

$ Change

 

 

% Change

 

Revenue

 

$

53,992

 

 

$

31,199

 

 

$

22,793

 

 

 

73

%

Cost of revenue

 

 

43,529

 

 

 

26,846

 

 

 

16,683

 

 

 

62

%

Gross profit

 

 

10,463

 

 

 

4,353

 

 

 

6,110

 

 

 

140

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

4,282

 

 

 

2,346

 

 

 

1,936

 

 

 

83

%

Sales and marketing

 

 

4,660

 

 

 

2,989

 

 

 

1,671

 

 

 

56

%

General and administrative

 

 

12,364

 

 

 

6,537

 

 

 

5,827

 

 

 

89

%

Total operating expenses

 

 

21,306

 

 

 

11,872

 

 

 

9,434

 

 

 

79

%

Loss from operations

 

 

(10,843

)

 

 

(7,519

)

 

 

3,324

 

 

 

44

%

Other income, net

 

 

47

 

 

 

11

 

 

 

36

 

 

NM

 

Financial expense, net

 

 

(908

)

 

 

(518

)

 

 

390

 

 

 

75

%

Foreign currency loss

 

 

(191

)

 

 

(415

)

 

 

(224

)

 

 

(54

%)

Loss before income tax benefit

 

 

(11,895

)

 

 

(8,441

)

 

 

3,454

 

 

 

41

%

Income tax benefit

 

 

(7,408

)

 

 

(313

)

 

 

7,095

 

 

NM

 

Net loss

 

$

(4,487

)

 

$

(8,128

)

 

$

(3,641

)

 

 

(45

%)

 

NM = Not meaningful

Revenue

In the three months ended June 30, 2021, revenue increased by $22.8 million, or 73%, compared to the three months ended June 30, 2020. This increase was mainly driven by the organic growth of the Kaleyra legacy businesses, representing 40% of the aggregate growth period over period, and the effects of the business combination with mGage, which contributed $10.2 million.

Cost of Revenue and Gross Profit

In the three months ended June 30, 2021, cost of revenue increased by $16.7 million, or 62%, compared to the three months ended June 30, 2020. The increase in cost of revenue was primarily attributable to the first-time consolidation of the newly acquired business of mGage and the amortization of acquired intangible assets. In the three months ended June 30, 2021, gross profit increased by 140% compared to the three months ended June 30, 2020, mainly as a result of the organic growth of the Kaleyra legacy businesses, representing 78% of the aggregate growth period over period, and the effects of the business combination with mGage.

Operating Expenses

In the three months ended June 30, 2021, research and development expenses increased by $1.9 million, compared to the three months ended June 30, 2020. Research and development expenses included $806,000 of stock-based compensation, compared to $1.1 million in the three months ended June 30, 2020. Excluding such costs and the $865,000 capitalized software development costs, compared to $619,000 capitalized costs in the three months ended June 30, 2020, research and development expenses would have increased by $2.5 million mainly due to an increase in headcount compared to the prior period and to the first-time consolidation of the newly acquired business of mGage, representing 53% of the increase in research and development expenses.

In the three months ended June 30, 2021, sales and marketing expenses increased by $1.7 million compared to the three months ended June 30, 2020. Sales and marketing expenses included $866,000 of stock-based compensation, compared to $1.1 million in the three months ended June 30, 2020. Excluding such costs, sales and marketing expenses would have increased by $1.9 million. Such increase was primarily driven by an increase in headcount compared to the prior period, to the first-time consolidation of the newly acquired business of mGage, representing 27% of the increase in sales and marketing expenses, and the amortization of acquired intangible assets.

In the three months ended June 30, 2021, general and administrative expenses increased by $5.8 million compared to the three months ended June 30, 2020. General and administrative expenses included (i) $3.0 million of stock-based compensation in the three months ended June 30, 2021, compared to $2.4 million in the three months ended June 30, 2020; and (ii) $3.7 million of mGage acquisition transaction costs and $1.8 million of transaction costs and costs pertaining to initial public company compliance in the three months ended June 30, 2021 and 2020, respectively. Excluding such costs, general and administrative expenses would have

35


 

increased by $3.3 million mainly due to an increase in the headcount compared to the same period of last year and mGage transaction-related advisory costs.

Other Income, Net

In the three-month period ended June 30, 2021, other income, net increased by $36,000, compared to three months ended June 30, 2020.

Financial Expense, Net

In the three months ended June 30, 2021, financial expense, net increased by $390,000, compared to the same period last year, from a financial expense of $518,000 to a financial expense of $908,000. Such increase in financial expense is mainly attributable to the accrued contractual interest expense and amortization of issuance costs amounting to $973,000 and $196,000, respectively, partially offset by the decrease in the fair value of the private warrant liability of $433,000. Excluding the net change in fair value of the warrant of $433,000 and the interest expense on convertible notes of $1.2 million, financial expense, net would have decreased by $346,000.

Foreign Currency Loss

In the three months ended June 30, 2021, foreign currency loss decreased by $224,000, compared to three months ended June 30, 2020. Such change was mainly attributable to the effects of the fluctuation of the Indian Rupee and Euro against the U.S. dollar.

Income Tax Benefit

In the three months ended June 30, 2021, income tax benefit increased by $7.1 million from an income tax benefit of $313,000 to an income tax benefit of $7.4 million, mainly due to a $5.8 million release of valuation allowance related to previously reserved deferred tax assets which the Company has determined will be utilized in the future to offset net deferred tax liabilities related to the mGage acquisition during the period and a $959,000 discrete tax benefit related to a release of the domestic valuation allowance associated with a net operating loss carryback during the three months ending June 30, 2021.

Comparison of the six months ended June 30, 2021 and 2020

 

 

 

Six Months Ended June 30,

 

 

 

 

 

 

2021

 

 

2020

 

 

$ Change

 

 

% Change

 

Revenue

 

$

93,706

 

 

$

64,832

 

 

$

28,874

 

 

 

45

%

Cost of revenue

 

 

76,919

 

 

 

55,748

 

 

 

21,171

 

 

 

38

%

Gross profit

 

 

16,787

 

 

 

9,084

 

 

 

7,703

 

 

 

85

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

7,150

 

 

 

5,156

 

 

 

1,994

 

 

 

39

%

Sales and marketing

 

 

7,519

 

 

 

6,732

 

 

 

787

 

 

 

12

%

General and administrative

 

 

22,966

 

 

 

14,296

 

 

 

8,670

 

 

 

61

%

Total operating expenses

 

 

37,635

 

 

 

26,184

 

 

 

11,451

 

 

 

44

%

Loss from operations

 

 

(20,848

)

 

 

(17,100

)

 

 

3,748

 

 

 

22

%

Other income, net

 

 

92

 

 

 

53

 

 

 

39

 

 

 

74

%

Financial expense, net

 

 

(1,627

)

 

 

(559

)

 

 

1,068

 

 

NM

 

Foreign currency income (loss)

 

 

164

 

 

 

(247

)

 

 

411

 

 

NM

 

Loss before income tax benefit

 

 

(22,219

)

 

 

(17,853

)

 

 

4,366

 

 

 

24

%

Income tax benefit

 

 

(7,374

)

 

 

(902

)

 

 

6,472

 

 

NM

 

Net loss

 

$

(14,845

)

 

$

(16,951

)

 

$

(2,106

)

 

 

(12

%)

 

NM = Not meaningful

Revenue

In the six months ended June 30, 2021, revenue increased by $28.9 million, or 45%, compared to the six months ended June 30, 2020. This increase was mainly driven by the organic growth of the Kaleyra legacy businesses, representing 29% of the aggregate growth period over period, and the effects of the business combination with mGage, which contributed $10.2 million.

36


 

Cost of Revenue and Gross Profit

In the six months ended June 30, 2021, cost of revenue increased by $21.2 million, or 38%, compared to the six months ended June 30, 2020. The increase in cost of revenue was primarily attributable to the first-time consolidation of the newly acquired business of mGage and the amortization of acquired intangible assets. In the six months ended June 30, 2021, gross profit increased by 85% compared to the six months ended June 30, 2020, mainly as a result of the organic growth of the Kaleyra legacy businesses, representing 52% of the aggregate growth period over period, and the effects of the business combination with mGage.

Operating Expenses

In the six months ended June 30, 2021, research and development expenses increased by $2.0 million, compared to the six months ended June 30, 2020. Research and development expenses included $1.8 million of stock-based compensation in the six months ended June 30, 2021, compared to $2.5 million of stock-based compensation and $524,000 for the Solutions Infini performance bonuses and preference shares amendment in the six months ended June 30, 2020. Excluding such costs and the $1.7 million capitalized software development costs, compared to $1.3 million capitalized costs in the six months ended June 30, 2020, research and development expenses would have increased by $3.5 million mainly due to an increase in headcount compared to the prior period and to the first-time consolidation of the newly acquired business of mGage, representing 38% of the increase in research and development expenses.

In the six months ended June 30, 2021, sales and marketing expenses increased by $787,000 compared to the six months ended June 30, 2020. Sales and marketing expenses included $1.4 million of stock-based compensation in the six months ended June 30, 2021, compared to $2.2 million of stock-based compensation and $1.1 million for the Solutions Infini performance bonuses and preference shares amendment in the six months ended June 30, 2020. Excluding such costs, sales and marketing expense would have increased by $2.6 million. Such increase was primarily driven by an increase in headcount compared to same period last year, to the first-time consolidation of the newly acquired business of mGage, representing 20% of the increase in sales and marketing expenses, and the amortization of acquired intangible assets.

In the six months ended June 30, 2021, general and administrative expenses increased by $8.7 million compared to the six months ended June 30, 2020. General and administrative expenses included (i) $6.1 million of stock-based compensation in the six months ended June 30, 2021, compared to $6.2 million in the six months ended June 30, 2020; and (ii) $5.5 million of mGage acquisition transaction costs and $2.6 million of transaction costs and costs pertaining to initial public company compliance in the six months ended June 30, 2021 and 2020, respectively. Excluding such costs, general and administrative expenses would have increased by $5.8 million, mainly due to an increase in the headcount compared to the same period of last year and mGage transaction-related advisory costs.

Other Income, Net

In the six-month period ended June 30, 2021, other income, net increased by $39,000, compared to six months ended June 30, 2020.

Financial Expense, Net

In the six months ended June 30, 2021, financial expense, net increased by $1.1 million, compared to the same period last year, from a financial expense of $559,000 to a financial expense of $1.6 million. Such increase in financial expense is mainly attributable to the increase in the fair value of the private warrant liability of $830,000, and to accrued contractual interest expense and amortization of issuance costs amounting to $973,000 and $196,000, respectively, partially offset by the reversal of interest expense of $659,000 previously accrued on a forward share purchase agreement in the six months ended June 30, 2021 compared to same period last year. The same period last year accounted for the reversal of interest expense of $417,000 previously accrued on the preference share obligations related to the amendment signed in January 2020. Excluding the increase in the fair value of the warrant of $830,000, the interest expense on convertible notes of $1.2 million and the non-recurring reversal of interest expense on a forward share purchase agreement and preference share obligations, amounting to $659,000 and $417,000, respectively, financial expense, net would have decreased by $688,000.

Foreign Currency Income (Loss)

In the six months ended June 30, 2021, there was foreign currency income of $164,000 compared to a foreign currency loss of $247,000 in the six months ended June 30, 2020. Such change was mainly attributable to the effects of the fluctuation of the Indian Rupee and Euro against the U.S. dollar.

Income Tax Benefit

In the six months ended June 30, 2021, income tax benefit increased by $6.5 million from an income tax benefit of $902,000 to an income tax benefit of $7.4 million mainly due to a $5.8 million release of the valuation allowance related to previously reserved

37


 

deferred tax assets which the Company has determined will be utilized in the future to offset net deferred tax liabilities related to the mGage acquisition during the period and a $959,000 discrete tax benefit related to a release of the domestic valuation allowance associated with a net operating loss carryback during the three months ending June 30, 2021.

LIQUIDITY AND CAPITAL RESOURCES

As of June 30, 2021, the Company had $118.6 million of cash and cash equivalents and $6.1 million of short-term investments with maturity terms between 4 and 12 months held in India. Of the $124.7 million in cash and short-term investments, $75.2 million was held in U.S. banks, $39.7 million was held in Italy, $7.6 million was held in India with the remainder held in other banks. As of December 31, 2020, the Company had $33.0 million of cash and cash equivalents and $4.8 million of short-term investments.

The condensed consolidated balance sheets as of June 30, 2021 includes total current assets of $209.9 million and total current liabilities of $103.1 million, resulting in net current assets of $106.8 million.

On February 18, 2021, and for the purposes of raising the cash portion of the consideration for the Merger, Kaleyra entered into the PIPE Subscription Agreements with the PIPE Investors and the Convertible Note Subscription Agreements with the Convertible Note Investors. Pursuant to these agreements, and prior to the closing of the Merger on June 1, 2021, Kaleyra issued an aggregate of $105 million or 8,400,000 shares of Kaleyra common stock to the PIPE Investors at $12.50 per share and $200 million aggregate principal amount of unsecured Merger Convertible Notes.

On February 25, 2021, in accordance with the terms of the Confirmation, NGFP fully terminated the Forward Transaction and made a payment in the aggregate amount of $17.0 million to Kaleyra. Following the cash settlement of the Forward Transaction mentioned above, the Forward Transaction with NGFP has terminated pursuant to the terms of the Confirmation, and as a result the Company has no further obligations.

Management currently plans to retain the cash in the jurisdictions where these funds are currently held. Kaleyra believes its cash, cash flows from operations and availability of borrowings will be sufficient to support its planned operations for at least the next 12 months.

Kaleyra finances its operations through a combination of cash generated from operations and from borrowings under Kaleyra bank facilities primarily with banks located in Italy. Kaleyra’s long-term cash needs primarily include meeting debt service requirements, working capital requirements and capital expenditures.

Kaleyra may also pursue strategic acquisition opportunities that may impact its future cash requirements. There are a number of factors that may negatively impact its available sources of funds in the future including the ability to generate cash from operations, obtain additional financing or refinance existing short-term debt obligations, including those related to acquisitions completed in prior periods. The amount of cash generated from operations is dependent upon factors such as the successful execution of Kaleyra’s business strategies and worldwide economic conditions. The amount of debt available under future financings is dependent on Kaleyra’s ability to maintain adequate cash flow for debt service and sufficient collateral, and general financial conditions in Kaleyra’s market.

As noted above, Kaleyra entered into the Convertible Note Subscription Agreements with the Convertible Note Investors pursuant to which Kaleyra agreed to issue $200 million in aggregate principal of Merger Convertible Notes. Subject to the terms of the Merger Convertible Notes, Kaleyra may opportunistically raise debt capital, subject to market and other conditions, to refinance its existing capital structure at a lower cost of capital and extend the maturity period of certain debt. Additionally, Kaleyra may also raise debt capital for strategic opportunities which may include acquisitions of additional companies, and general corporate purposes. If additional financing is required from outside sources, Kaleyra may not be able to raise it on terms acceptable to it or at all. If Kaleyra is unable to raise additional capital when desired, Kaleyra’s business, operating results and financial condition may be adversely affected.

Kaleyra has a number of long-standing business and banking relationships with major Italian commercial banks where it maintains both cash accounts and a credit relationship. Historically, Kaleyra has used cash generated from operations to fund its growth and investment opportunities. As Kaleyra’s management made the decision to expand its operations outside of Italy and acquire additional companies, it took on certain additional financing in order to fund cash payments due on the acquisitions. As of June 30, 2021, Kaleyra’s total bank and other borrowings, including amounts drawn under the revolving credit line facilities was $43.4 million ($48.0 million as of December 31, 2020).

Kaleyra has credit line facilities of $7.5 million as of June 30, 2021, of which $5.3 million has been used. As of December 31, 2020, Kaleyra had credit line facilities of $7.7 million, of which $5.3 million had been used. Amounts drawn under the credit line facilities are collateralized by specific customer trade receivables and funds available under the line are limited based on eligible receivables.

38


 

Notes Payable - Other

On April 16, 2020, in connection with the Business Combination, Kaleyra entered into a Settlement Agreement and Release (the “Settlement Agreement”) with its financial advisory service firms, Cowen and Company, LLC (“Cowen”) and Chardan Capital Markets, LLC, (“Chardan” and collectively the “Service Firms”), pursuant to which it agreed to pay an affiliate of Cowen, Cowen Investments II LLC (“Cowen Investments”), and Chardan, in full satisfaction of all amounts owed to the Service Firms as of December 31, 2019, $5.4 million in the aggregate, as follows: (i) $2.7 million in the aggregate in common stock of Kaleyra (the “Settlement Shares”) to be issued the business day prior to the filing of a resale registration statement for such Settlement Shares (the “Resale Registration Statement”), (ii) convertible notes totaling $2.7 million in the aggregate with a maturity date three years after issuance and bearing interest at five percent (5%) per annum (but with lower interest rates if the notes are repaid earlier than one year or two years after issuance) and with interest paid in arrears to the payee on March 15, June 15, September 15 and December 15 of each year, with such convertible notes to also be issued the business day prior to the filing of the Resale Registration Statement and (iii) in the event that the Beneficial Ownership Limitation (as defined below) would otherwise be exceeded upon delivery of the Settlement Shares above, a warrant agreement also to be entered into with and issued to the Services Firms the business day prior to the filing of the Resale Registration Statement, whereby the amount of common stock of Kaleyra by which the Beneficial Ownership Limitation would otherwise have been exceeded upon delivery of the Settlement Shares will be substituted for by warrants with an exercise price of $0.01 per share issued pursuant to a Warrant Agreement (the “Warrant Agreement”) and the common stock underlying the Warrant Agreement (the “Warrant Shares”). The Beneficial Ownership Limitation shall initially be 4.99% of the number of shares of the common stock outstanding of Kaleyra immediately after giving effect to the issuance of these shares of common stock. The number of Settlement Shares was calculated using as the price per Settlement Share an amount equal to a fifteen percent (15%) discount to the ten-day (10-day) trailing dollar volume-weighted average price for the common stock of Kaleyra on the NYSE American LLC stock exchange (the “VWAP”) on the business day immediately prior to the date on which Kaleyra files the Resale Registration Statement. In addition, the price per share for determining the number of shares of common stock of Kaleyra to be issued upon the conversion of the convertible notes shall be a five percent (5%) premium to the ten-day (10-day) trailing VWAP as of the date immediately prior to the issuance date of the convertible notes, rounded down to the nearest whole number.

On May 1, 2020, in connection with the Settlement Agreement, Kaleyra issued: (i) an aggregate of 440,595 Settlement Shares to Cowen Investments and Chardan, consisting of 374,506 Settlement Shares issued to Cowen Investments, and 66,089 Settlement Shares issued to Chardan; and (ii) convertible promissory notes in the aggregate principal amount of $2.7 million to Cowen Investments and Chardan, consisting of a convertible promissory note in the principal amount of $2.3 million issued to Cowen Investments (the “Cowen Note”) and a convertible promissory note in the principal amount of $405,000 issued to Chardan (the “Chardan Note”). The unpaid principal of the Cowen Note is convertible at the option of Cowen Investments into 303,171 shares of common stock of Kaleyra, if there has been no principal reduction, and the unpaid principal of the Chardan Note is convertible at the option of Chardan into 53,501 shares of common stock of Kaleyra, if there has been no principal reduction. As the Beneficial Ownership Limitation was not triggered by the issuance of the Settlement Shares, no Warrant Agreement was necessary and no warrants were issued.

On February 4, 2021, Cowen Investments elected to convert the outstanding amount of the Cowen Note into 303,171 shares of common stock pursuant to the terms of the Cowen Note, and as a result the Company has no further obligations with respect to the Cowen Note.

As of June 30, 2021, the outstanding amount of the Chardan Note was $405,000 and accrued interest was $24,000.

Notes Payable to the Sellers

As mentioned above, at the Closing of the Business Combination, Kaleyra issued unsecured convertible promissory notes to each of Esse Effe and Maya in the amount of $6.0 million and $1.5 million, respectively, and also issued other unsecured promissory notes to each of Esse Effe and Maya in the identical respective amounts (the “Notes payable to the Sellers”). The unsecured promissory notes held by Esse Effe and Maya were paid in full during fiscal year 2020 and no amount remains outstanding for such notes as of June 30, 2021. Interest on the Notes Payable to the Sellers shall accrue at a fixed interest rate equal to the one-year U.S. dollar LIBOR interest rate published in The Wall Street Journal on the date of the Business Combination, plus a margin of one percent (1%) per annum.

On the fifteen-month anniversary of the Business Combination Date or February 25, 2021, fifty percent (50%) of the previously outstanding amount of the unsecured convertible promissory notes held by Esse Effe and Maya was repaid, with a total of $3.0 million and $750,000 in principal and $176,000 and $44,000 in accrued interest being paid to Esse Effe and Maya, respectively, pursuant to the terms of the Business Combination Convertible Notes.

Under the terms of the unsecured convertible promissory notes, the outstanding principal balance of the notes, plus all accrued and unpaid interest and fees due under these notes, became due and payable, upon the receipt by the Company of cash proceeds of an equity financing in an aggregate gross amount of $105.0 million or 8,400,000 shares of Kaleyra common stock at $12.50 per share issued to the PIPE Investors in the private placement equity financing event immediately prior to the closing of the Merger Agreement

39


 

of June 1, 2021. The principal amount of $3.8 million plus accrued interest of $84,000 for the unsecured convertible promissory notes held by Esse Effe and Maya was paid in full on June 2, 2021. Following the payment of the previously outstanding amount of convertible notes, the Notes Payable to Sellers terminated pursuant to their terms and no further amounts were due.

Forward Share Purchase Agreements Obligations

On February 25, 2021, in accordance with the terms of the agreement (the “Confirmation”) with Nomura Global Financial Products, Inc. (“NGFP”), NGFP fully terminated the Forward Transaction and made a payment in the aggregate amount of $17.0 million to Kaleyra. Following the cash settlement of the Forward Transaction mentioned above, the Forward Transaction with NGFP has terminated pursuant to the terms of the Confirmation, and as a result the Company has no further obligations.

During the period from January 25, 2021 through March 2, 2021, Yakira provided notice to the Company that it sold all but 219 of the 43,930 shares that it held on December 31, 2020 in the open market at a price above $11.00 per share that were subject to the Third Yakira Amendment. On March 29, 2021 Yakira provided notice to the Company that it would not require the Company to purchase its remaining 219 shares by the term date of March 31, 2021. Following the sale of shares and the lapse of the Third Yakira Amendment mentioned above, the forward share purchase agreement with Yakira terminated pursuant to its terms, and as a result the Company has no further obligations under the Yakira Purchase Agreement. As of June 30, 2021 there are no outstanding obligations under the Forward Share Purchase Agreement.

Merger Convertible Notes

On February 18, 2021, in support of the consummation of the Merger, Kaleyra entered into Convertible Note Subscription Agreements, each dated February 18, 2021, with the Convertible Note Investors. In June 2021, the Company issued the Merger Convertible Notes with an aggregate principal amount of $200 million. The Company incurred $11.4 million of issuance costs as a result of the issuance of the Merger Convertible Notes.

In connection with the issuance of the Merger Convertible Notes pursuant to the terms of the Convertible Note Subscription Agreements, the Company entered into an indenture (the “Indenture”) with Wilmington Trust, National Association, a national banking association, in its capacity as trustee thereunder (the “Indenture Trustee”), in respect of the $200 million of Merger Convertible Notes that were issued to the Convertible Note Investors.

The Merger Convertible Notes bear interest at a rate of 6.125% per annum, payable semi-annually, in arrears on each June 1 and December 1 of each year, commencing on December 1, 2021, to holders of record at the close of business on the preceding May 15 and November 15, respectively. The Merger Convertible Notes are convertible into 11,851,852 shares of Parent Common Stock at a conversion price of $16.875 per share of Parent Common Stock in accordance with the terms of the Indenture, and mature five years after their issuance. The Company may, at its election, force conversion of the Merger Convertible Notes after (i) the first anniversary of the issuance of the Merger Convertible Notes, subject to a holder’s prior right to convert, if the last reported sale price of the Parent Common Stock exceeds 150% of the conversion price for at least 20 trading days during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter and (ii) the second anniversary of the issuance of the Merger Convertible Notes, subject to a holder’s prior right to convert, if the last reported sale price of the Parent Common Stock exceeds 130% of the conversion price for at least 20 trading days during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter. Following certain corporate events that occur prior to the maturity date or if the Company forces a mandatory conversion, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Merger Convertible Notes in connection with such a corporate event or has its Merger Convertible Notes mandatorily converted, as the case may be. In addition, in the event that a holder of the Merger Convertible Notes elects to convert its Merger Convertible Notes prior to the third anniversary of the issuance of the Merger Convertible Notes, the Company will be obligated to pay an amount equal to twelve months of interest, or if on or after such third anniversary of the issuance of the Merger Convertible Notes, any remaining amounts that would be owed to, but excluding, the fourth anniversary of the issuance of the Merger Convertible Notes (the “Interest Make-Whole Payment”). The Interest Make-Whole Payment will be payable in cash or shares of Parent Common Stock as set forth in the Indenture.

Upon the issuance of the Merger Convertible Notes management made the assessment whether the convertible instrument contained embedded conversion features for bifurcation and concluded that such embedded conversion features met the definition of a derivative but qualified for the scope exception under ASC 815-10-15-74(a) as they are indexed to the Company’s stock and qualify for classification within stockholders’ equity. Management determined that the Interest Make-Whole Payment met the definition of a derivative, but the value was de minimis and as such no amount was recorded at the time of the issuance of the Merger Convertible Notes. Management will continue to monitor the valuation of the Interest Make-Whole Payment provision and assess the need to record a liability in future periods.

As of June 30, 2021, the outstanding amount of the Merger Convertible Notes was $188.8 million, net of issuance costs. During the one-month period following the issuance of the convertible notes accrued contractual interest and amortization of issuance costs amounted to $973,000 and $196,000, respectively. The liability is included in the condensed consolidated balance sheet line item

40


 

“Long-term portion of notes payable” and the interest expense is included in “Finance (income) expense, net” on the condensed consolidated statements of operations.

Long-term financial obligations

Long-term financial obligations, excluding Debt for Forward Share Purchase Agreements, the Notes Payable to the Sellers, the Notes Payable to the Founders, Merger Convertible Notes and credit line facilities, consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Nominal Rate

 

 

 

As of

June 30,

 

 

As of

December 31,

 

 

 

 

Interest

 

 

As of

June 30,

 

 

As of

December 31,

 

 

 

2021

 

 

2020

 

 

Maturity

 

Contractual Rate

 

 

2021

 

 

2020

 

UniCredit S.p.A.

   (Line A Tranche 1)

 

$

2,787

 

 

$

3,235

 

 

July 2023

 

Euribor 3 months + 3.10%

 

 

 

2.80

%

 

 

2.80

%

UniCredit S.p.A.

   (Line A Tranche 2)

 

 

133

 

 

 

153

 

 

November 2023

 

Euribor 3 months + 3.10%

 

 

 

2.80

%

 

 

2.80

%

UniCredit S.p.A. (Line B)

 

 

2,691

 

 

 

3,030

 

 

May 2024

 

Euribor 3 months + 2.90%

 

 

 

2.60

%

 

 

2.60

%

UniCredit S.p.A. (Line C)

 

 

2,182

 

 

 

2,521

 

 

August 2023

 

Euribor 3 months + 3.90%

 

 

 

3.36

%

 

 

3.36

%

Intesa Sanpaolo S.p.A.

   (Line 1)

 

 

603

 

 

 

931

 

 

April 2022

 

Euribor 3 months + 1.80%

 

 

 

1.26

%

 

 

1.26

%

Intesa Sanpaolo S.p.A.

   (Line 2)

 

 

3,587

 

 

 

4,292

 

 

April 2024

 

Euribor 3 months + 2.60%

 

 

 

2.06

%

 

 

2.06

%

Intesa Sanpaolo S.p.A.

   (Line 3)

 

 

9,384

 

 

 

9,688

 

 

June 2026

 

Euribor 3 months + 1.65%

 

 

 

1.11

%

 

 

1.11

%

Intesa Sanpaolo S.p.A.

   (Line 4)

 

 

6,523

 

 

 

6,734

 

 

July 2026

 

Euribor 3 months + 1.70%

 

 

 

1.16

%

 

 

1.16

%

UBI Banca S.p.A. (Line 1)

 

 

51

 

 

 

209

 

 

August 2021

 

Euribor 3 months + 1.25%

 

 

 

1.25

%

 

 

1.25

%

UBI Banca S.p.A. (Line 2)

 

 

401

 

 

 

1,031

 

 

October 2021

 

Euribor 3 months +1.95%

 

 

 

1.41

%

 

 

1.41

%

Monte dei Paschi di

   Siena S.p.A. (Line 1)

 

 

199

 

 

 

328

 

 

April 2022

 

 

0.95

%

 

 

0.95

%

 

 

0.95

%

Monte dei Paschi di

   Siena S.p.A. (Line 2)

 

 

1,579

 

 

 

2,037

 

 

June 2023

 

 

1.50

%

 

 

1.50

%

 

 

1.50

%

Banco BPM S.p.A. (Line 1)

 

 

824

 

 

 

1,056

 

 

June 2023

 

Euribor 3 months + 2.00%

 

 

 

2.00

%

 

 

2.00

%

Banco BPM S.p.A. (Line 3)

 

 

6,169

 

 

 

6,355

 

 

September 2024

 

Euribor 3 months + 3.00%

 

 

 

2.46

%

 

 

2.46

%

Simest 1

 

 

248

 

 

 

307

 

 

December 2023

 

 

0.50

%

 

 

0.50

%

 

 

0.50

%

Simest 2

 

 

246

 

 

 

305

 

 

December 2023

 

 

0.50

%

 

 

0.50

%

 

 

0.50

%

Simest 3

 

 

452

 

 

 

560

 

 

December 2023

 

 

0.50

%

 

 

0.50

%

 

 

0.50

%

Total bank and other borrowings

 

 

38,059

 

 

 

42,772

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less: current portion

 

 

9,448

 

 

 

10,798

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total long-term portion

 

$

28,611

 

 

$

31,974

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All bank and other borrowings are unsecured borrowings of Kaleyra.

Cash Flows

The following table summarizes cash flows for the periods indicated (in thousands):

 

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

Net cash used in operating activities

 

$

(13,113

)

 

$

(4,421

)

Net cash used in investing activities

 

 

(198,858

)

 

 

(1,734

)

Net cash provided by financing activities

 

 

298,035

 

 

 

6,776

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

(409

)

 

 

(370

)

Net increase in cash, cash equivalents and restricted cash

 

$

85,655

 

 

$

251

 

In the six months ended June 30, 2021, cash used in operating activities was $13.1 million, primarily consisting of net loss of $14.8 million and $5.6 million of net changes in operating assets and liabilities, partially offset by non-cash items, mainly $9.3 million

41


 

of stock-based compensation, $830,000 of change in the fair value of the warrant liability, $3.5 million of depreciation and amortization expense and $325,000 of non-cash interest expense, partially offset by $6.8 million of deferred tax benefit.

In the six months ended June 30, 2020, cash used in operating activities was $4.4 million, primarily consisting of net loss of $17.0 million partially offset by $9.7 million of non-cash items and net cumulative changes in operating assets and liabilities of $2.8 million. Non-cash items consisted primarily of $11.1 million of stock-based compensation and $1.3 million of depreciation and amortization expense partially offset by $2.5 million settlement on the preference share liability and $636,000 change in deferred tax assets.

In the six months ended June 30, 2021, cash used in investing activities was $198.9 million, primarily consisting of $195.7 million of cash consideration paid for the acquisition of mGage, $1.9 million of purchases in short-term investments, $1.6 million to fund the cost of internally developed software and $177,000 of purchases in property and equipment, partially offset by $546,000 of proceeds from sale of short-term investments.

In the six months ended June 30, 2020, cash used in investing activities was $1.7 million, primarily consisting of $4.9 million of purchases of short-term investments and $1.4 million to fund the cost of internally developed software, partially offset by $5.0 million of proceeds from sale of short-term investments.

In the six months ended June 30, 2021, cash provided by financing activities was $298.0 million, primarily consisting of $188.6 million of proceeds from issuance of convertible notes, net of issuance costs, $99.1 million of proceeds from issuance of common stock in Private Investment in Public Equity offering, net of issuance costs, $17.0 million of receipts related to forward share purchase agreements, $2.9 million in proceeds received from the exercise of warrants, $1.2 million in proceeds related to the settlement of non-forfeited 2020 Sponsor Earnout Shares, partially offset by $7.5 million of repayments on notes and $3.5 million of repayments on term loans.

In the six months ended June 30, 2020, cash provided by financing activities was $6.8 million, primarily consisting of $32.7 million in net proceeds from the public offering of the Company’s common stock, $8.8 million in proceeds from borrowings on term loans and net drawings of $1.4 million on the available lines of credit, partially offset by $5.7 million of repayments on term loans, $24.2 million of repurchases of common stock related to forward share purchase agreements and $5.5 million of repayments on notes.

Contractual Obligations and Other Commitments

The following table summarizes the obligations as of June 30, 2021, as derived from the unaudited consolidated financial statements of Kaleyra as of that date. The table should be read in connection with the footnotes below describing certain events occurring after June 30, 2021 (in thousands).

 

 

 

Payment due by period

 

 

 

Total

 

 

2021 (remaining six months)

 

 

2022-2024

 

 

2025-2026

 

 

Thereafter

 

Bank and other borrowings

 

$

38,059

 

 

$

4,337

 

 

$

27,869

 

 

$

5,853

 

 

$

 

Line of credit

 

 

5,338

 

 

 

5,338

 

 

 

 

 

 

 

 

 

 

Capital lease obligations (including interest)

 

 

291

 

 

 

73

 

 

 

200

 

 

 

18

 

 

 

 

Operating lease obligations (1)

 

 

3,742

 

 

 

720

 

 

 

2,525

 

 

 

497

 

 

 

 

Convertible notes (2)

 

 

200,000

 

 

 

 

 

 

 

 

 

200,000

 

 

 

 

Other notes payable (3)

 

 

405

 

 

 

 

 

 

405

 

 

 

 

 

 

 

Total

 

$

247,835

 

 

$

10,468

 

 

$

30,999

 

 

$

206,368

 

 

$

 

 

 

(1)

The Company has an option to extend its Milan office lease in 2026 for a period of 6 years under the same terms and conditions of the existing contract.

 

(2)

Pursuant to Convertible Note Subscription Agreements with the Convertible Note Investors, on June 1, 2021, prior to the closing of the Merger, Kaleyra issued and sold in private placements $200 million aggregate principal amount of unsecured Merger Convertible Notes.

 

(3)

On May 1, 2020, the Company issued to Chardan convertible promissory notes in the aggregate principal amount of $405,000 as a partial settlement of the amounts owed to Chardan for financial advisory services provided by Chardan to Kaleyra S.p.A. in connection with the previously consummated Business Combination. The unpaid principal of the Chardan Note is convertible at the option of Chardan into 53,501 shares of common stock of the Company, if there has been no principal reduction.

42


 

Off-Balance Sheet Arrangements

As of June 30, 2021, Kaleyra did not have any relationships with any entities or financial partnerships, such as structured finance or special purposes entities established for the purpose of facilitating off-balance sheet arrangements or for other purposes.

Seasonality

Historically, Kaleyra has experienced clear seasonality in its revenue generation, with slower traction in the first calendar quarter, and increasing revenues as the year progresses toward the higher revenues in messaging and notification services during the fourth calendar quarter. This patterned revenue generation behavior takes place due to Kaleyra’s customers sending more messages to their end-user customers who are engaged in consumer transactions at the end of the calendar year, resulting in an increase in notifications of electronic payments, credit card transactions and e-commerce.

Taxes

The Company files income tax returns in the United States and in foreign jurisdictions including Italy, India, and Switzerland. As of June 30, 2021, the tax years 2008 through the current period remain open to examination in each of the major jurisdictions in which the Company is subject to tax.

The Company recorded an income tax benefit of $7.4 million and $313,000 for the three months ended June 30, 2021 and 2020, respectively, and an income tax benefit of $7.4 million and $902,000 for the six months ended June 30, 2021 and 2020, respectively.

As of June 30, 2021, the Company maintained $5.3 million of undistributed earnings and profits generated by a foreign subsidiary (Solutions Infini) for which no deferred tax liabilities have been recorded, since the Company intends to indefinitely reinvest such earnings in the subsidiary to fund the international operations and certain obligations of the subsidiary. Should the above undistributed earnings be distributed in the form of dividends or otherwise, the distributions would result in approximately $782,000 of tax expense.

Recent Accounting Pronouncements

See Note 2 - Summary of Significant Accounting Policies – to the condensed consolidated financial statements included in Part I of this Quarterly Report on Form 10-Q for more information on new accounting pronouncements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.

Item 4. Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective as of December 31, 2020, as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

Changes in Internal Control over Financial Reporting

During our most recently completed fiscal quarter ended June 30, 2021, the Company acquired mGage, and as a result of the acquisition, there are changes to the internal controls over financial reporting as mGage had its own such controls which are in the process of being integrated with the Company’s pre-acquisition internal controls over financial reporting. In accordance with applicable guidance from the SEC for acquisitions, the Company is at this time excluding mGage from management’s assessment of the Company’s internal control over financial reporting. Notwithstanding there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

43


 

PART II — OTHER INFORMATION

From time to time, Kaleyra may be involved in litigation relating to claims arising out of its operations in the normal course of business. Kaleyra is not currently involved in any material legal proceedings as a defendant.

On October 17, 2018, Kaleyra filed a claim against Vodafone Italia S.p.A. (“Vodafone”) before the Court of Milan seeking compensation in the amount of €6.1 million ($7.5 million at the December 31, 2020 exchange rate) for all the damages suffered as a consequence of the illicit and anticompetitive conduct of Vodafone, as previously determined by the Italian Antitrust Authority (namely, Autorità Garante della Concorrenza e del Mercato or AGCM) in their decisions issued on December 13, 2017; Vodafone has appealed that sanctioning resolution before the Italian Regional Administrative Court.

The deadline for filing a counterclaim by Vodafone has passed and according to Italian Law, Vodafone is no longer entitled to file a counterclaim against Kaleyra in these proceedings. Both Kaleyra and Vodafone have filed their final pleadings on October 1, 2019 and October 21, 2019.

The Court of Milan has decided to suspend the procedure, through order no. 1570 on May 18, 2020. The decision of the Court of Milan is based on procedural reasons only (concerning the unprecedented definition of the relationship between administrative and civil proceedings in the case at hand) and does not analyze or take into any consideration the merits of the action brought by Kaleyra. The procedural suspension ordered by the Court of Milan shall last until the appeal brought by Vodafone before the Italian Regional Administrative Court against the decision of the Italian Antitrust Authority is concluded with a definitive judgment. Accordingly, following the order of suspension issued by the Civil Court of Milan, on August 10, 2020, Kaleyra filed a request to speed up the scheduling of the hearing in relation to the pending appeal before the Italian Regional Administrative Court brought by Vodafone Italia. The Court upheld Kaleyra’s request and the hearing has taken place on February 24, 2021. Accordingly, the parties submitted their final defenses. The decision is expected to be released in the fiscal year 2021. The outcome of such action cannot be determined at this time. Therefore, no recognition of these actions has been made in the consolidated financial statements of the Company.

On April 16, 2019, Kaleyra filed a claim against Telecom Italia S.p.A and Telecom Italia Sparkle S.p.A. before the Court of Milan seeking compensation in the amount of €8.3 million ($10.2 million at the December 31, 2020 exchange rate) for damages suffered after the illicit conduct of both counterparts, determined by the Italian Antitrust Authority in the decision issued on December 13, 2017.

At the first hearing before the Court of Milan held for the appearance of the parties on December 11, 2019, the judge reserved the decision on the possible suspension of the case in consideration of the appeal brought by Telecom Italia S.p.A and Telecom Italia Sparkle S.p.A. against the Italian Antitrust Authority’s decision of December 13, 2017 before the Regional Administrative Court, which is currently pending.

By order issued on December 14, 2019, the judge released his reserve and referred the issue concerning the relation between the assessment of the pending administrative case and the one to be carried out in the civil case to a panel composed of three judges. The case was therefore adjourned for a hearing on April 29, 2020 where the parties had to file their final pleadings.

On April 9, 2020, following the measures taken by the Italian legislator for the Covid-19 pandemic, the above-mentioned hearing was postponed to and then held on October 7, 2020. At the hearing of October 7, 2020, the parties exposed their closing arguments and the decision on the preliminary question as to the suspension of the civil proceedings has been reserved to a panel composed of three judges. The parties also submitted written observations concerning the preliminary question.

On January 7, 2021, the Court issued an order by which the civil proceedings have been suspended until the decision in the pending administrative case – which was deemed to be prejudicial to the civil one – becomes final (i.e., it is no longer subject to appeal). The order was communicated to the parties via certified electronic mail on January 11, 2021.

In light of the average duration of cases before the Italian Administrative Courts and the Defendants’ interest in both having the Italian Competition Authority’s Decision annulled and procrastinating the administrative case (on which the civil proceedings now depend pursuant to the above-mentioned order) for dilatory purposes, the civil case is unlikely to proceed in the short term. In order to speed up the administrative proceedings (and thus the civil case), on February 9, 2021, Kaleyra filed an application with the Administrative Court of Latium requesting that the hearing on the merits of the case be held as soon as possible. However, neither the outcome of Kaleyra’s civil action nor its duration is predictable at this time.

The outcome of such civil action cannot be determined at this time. Therefore, no recognition of these actions has been made in the consolidated financial statements of the Company.

In addition to the above, Kaleyra has appealed the resolutions issued by the Italian Communications Authority (namely, Autorità per le Garanzie nelle Comunicazioni or AGCom) concerning their request for the annual fee to AGCom for years 2016, 2017, 2018, 2019 and 2020.

44


 

The first instance proceeding against AGCom’s resolutions for the 2016 contribution was successful for Kaleyra and the Italian Regional Administrative Court annulled the resolutions Kaleyra had appealed (judgement no. 2161/2019). However, AGCom filed its second instance appeal before the Council of State seeking the overruling of the Court’s decision. The appeal has been regularly discussed at the hearing of September 17, 2020 and the Council of State issued its decision number 6175/2020 on October 13, 2020, overruling in part the Regional Court Decision.  AGCom will have to recalculate the annual contribution due from Kaleyra for year 2016. However, the annual contribution is not considered material to Kaleyra’s consolidated financial statements.

For the annual contribution to AGCom relating the years 2017, 2018, 2019 and 2020 the legal proceedings are currently pending before the Italian Regional Administrative Court and no hearing has been scheduled yet. However, the European Court of Justice (“ECJ”) has already delivered its decision on the request for a preliminary ruling submitted by the Council of State on the relevant EU law (case C-399/18). Such decision was delivered on April 29, 2020, in accordance with a simplified procedure due to the previous issuance by the ECJ of a number of judgements on the matter.

Finally, Kaleyra took part in two appeals brought before the Regional Administrative Court of Lazio (TAR Lazio) by, respectively, an Association of Content Service Providers (“CSP”) for Value Added Services on mobile network (“VAS”), and one singular CSP, against a specific resolution of the Italian Communications Authority regarding the rules for applying a barring mechanism on the SIM of the final users of VAS (resolution no. 10/21/CONS). Kaleyra filed its interventions in both the judicial proceedings to support the measures issued by AGCom.

Specifically, following the hearing before TAR Lazio that took place on March 17, 2021, the Court has issued two orders (no. 1748 and no. 1751, dated March 18, 2021) that rejected the precautionary measures requested by both the plaintiffs, upholding the position represented by Kaleyra to support the legitimacy of the abovementioned resolution. Following the definition of the precautionary phase, both appeals are likely to be discussed on the merits in the next months. As of today, TAR Lazio has not scheduled any further hearing, hence there is no imminent deadline with regard to those judicial proceedings. For the sake of completeness, the final judgments of TAR Lazio on the two appeals above shall not result in any economic direct impact on Kaleyra.

Item 1A. Risk Factors

We have revised the risk factors that relate to our business, as set forth below. These risks include any material changes to and supersede any similar risks previously disclosed in Part I, Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2020 and otherwise supplement those risks. We encourage investors to review the risk factors and uncertainties relating to our business disclosed in that Form 10-K, as well as those contained in Part 1, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, above.

Kaleyra currently generates significant revenue from its largest customers, and the loss or decline in revenue from any of these customers could limit Kaleyra’s revenue and results of operations.

In the six months ended June 30, 2021 and 2020, Kaleyra’s 10 largest customers generated an aggregate of 42.3% and 52.0% of its revenue, respectively. The churn rate, calculated as the annual rate at which Kaleyra’s existing customers stopped subscribing for its services, was equal to zero in the six-month period ended June 30, 2021. In the event that Kaleyra’s large customers do not continue to use its products, use fewer of its products, or use its products in a more limited capacity, or not at all, Kaleyra’s revenue could be limited and Kaleyra’s business could be harmed.

Kaleyra has incurred significant transaction costs as a result of the acquisition of the mGage business, which could have a material adverse effect on our financial condition.

Kaleyra has incurred and will continue to incur significant one-time transaction costs related to the acquisition of the mGage business. These transaction costs include legal and accounting fees and expenses and filing fees, printing expenses and other related charges, including payments that were made to government authorities. Kaleyra may also incur additional unanticipated transaction costs in connection with the transaction. Additional costs will be incurred in connection with integrating the two companies’ businesses. Costs in connection with the transaction and integration may be higher than expected. These costs could adversely affect Kaleyra’s financial condition, operating results or prospects of the company following the completion of the acquisition

Kaleyra has experienced rapid internal growth as well as growth through acquisitions in recent periods. If Kaleyra fails to manage its growth effectively, or its business does not grow as expected, Kaleyra’s operating results may suffer.

Kaleyra’s headcount and operations have grown substantially, including as a result of the acquisition of the mGage business on June 1, 2021. Kaleyra had over 510 employees as of June 30, 2021, as compared with almost 300 employees as of June 30, 2020.  This growth has placed, and will continue to place, a significant strain on Kaleyra’s operational, financial, and management infrastructure. Kaleyra anticipates further increases in headcount will be required to support increases in its technology offerings and continued expansion. To manage this growth effectively, Kaleyra must continue to improve its operational, financial, and management systems and controls by, among other things:

45


 

 

effectively attracting, training, and integrating a large number of new employees, particularly technical personnel and members of Kaleyra’s management and sales teams;

 

further improving Kaleyra’s key business systems, processes, and information technology infrastructure to support Kaleyra’s business needs;

 

enhancing Kaleyra’s information and communication systems to ensure that Kaleyra’s employees are well-coordinated and can effectively communicate with each other and Kaleyra’s customers; and

 

improving Kaleyra’s internal control over financial reporting and disclosure controls and procedures to ensure timely and accurate reporting of Kaleyra’s operational and financial results.

If Kaleyra fails to manage its expansion or implement Kaleyra’s new systems, or if Kaleyra fails to implement improvements or maintain effective internal controls and procedures, Kaleyra’s costs and expenses may increase more than expected and Kaleyra may not expand its client base, increase existing customer volumes and renewal rates, enhance its existing applications, develop new applications, satisfy its customers, respond to competitive pressures, or otherwise execute its business plan. If Kaleyra is unable to manage its growth, Kaleyra’s operating results likely will be harmed.

Kaleyra’s future success depends in part on its ability to drive the adoption of its products by international customers.

In the six months ended June 30, 2021, and 2020, Kaleyra derived 64.6% and 66.7% of its revenue, respectively, from customer accounts located in Italy and India. Revenue deriving from customer accounts located in the United States increased from 16.4% in the six months ended June 30, 2020 to 17.2% in the six months ended June 30, 2021, while revenue deriving from customer accounts located in the European countries other than Italy decreased from 7.9% in the six months ended June 30, 2020 to 3.5% in the six months ended June 30, 2021. Revenue derived from customers located in South America accounted for 2.6% of consolidated revenue in the six months ended June 30, 2021. Revenue derived from customer accounts located in the rest of the world increased from 8.9% in the six months ended June 30, 2020 to 12.1% in the six months ended June 30, 2021. This is in line with the expansion strategy out of Italy and India identified by Kaleyra. The future success of Kaleyra’s business will depend, in part, on Kaleyra ability to expand its customer base worldwide in new geographies. If Kaleyra is unable to increase the revenue that it derives from international customers, Kaleyra’s business and results of operations could be harmed.

Kaleyra has incurred significant indebtedness as a result of the acquisition of the mGage business, which could have a material adverse effect on Kaleyra’s financial condition.

As of December 31, 2020, Kaleyra’s total consolidated long term indebtedness to banks and other lenders was approximately $32 million. On June 1, 2021, Kaleyra acquired the mGage business. In conjunction with such acquisition, Kaleyra incurred substantial indebtedness of $200 million through the issuance of unsecured convertible notes. Following this issuance and sale, Kaleyra is obligated under substantially more indebtedness than was the case prior to June 1, 2021. Kaleyra, with the acquisition of mGage, may not be able to generate sufficient cash to service all of its indebtedness and may be forced to take other actions to satisfy its obligations under indebtedness that may not be successful. The inability in the future to repay such indebtedness when due would have a material adverse effect on Kaleyra.

Kaleyra’s indebtedness could have important consequences to its stockholders and the holders of its other securities including:

 

increasing Kaleyra’s vulnerability to general adverse economic and industry conditions;

 

requiring that a portion of Kaleyra’s cash flow from operations be used for the payment of interest on its debt, thereby reducing its ability to use its cash flow to fund working capital, capital expenditures, acquisitions and general corporate requirements;

 

limiting Kaleyra’s ability to obtain additional financing to fund future working capital, capital expenditures, acquisitions and general corporate requirements;

 

limiting Kaleyra’s flexibility in planning for, or reacting to, changes in its business;

 

restricting Kaleyra’s ability or the ability to pay dividends or make other payments; and

 

placing Kaleyra at a competitive disadvantage to its competitors that have less indebtedness.

Kaleyra may be able to incur additional indebtedness in the future, including secured indebtedness. If new indebtedness is added to Kaleyra’s current indebtedness levels, the related risks that it faces could intensify.

If Kaleyra’s goodwill or intangible assets become impaired, Kaleyra may be required to record a significant charge to earnings.

Kaleyra reviews its intangible assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Goodwill is required to be tested for impairment at least annually. As of June 30, 2021, Kaleyra carried a net

46


 

$224.3 million of goodwill and intangible assets. An adverse change in market conditions, particularly if such change has the effect of changing one of Kaleyra’s critical assumptions or estimates, could result in a change to the estimation of fair value that could result in an impairment charge to Kaleyra’s goodwill or intangible assets. Any such charges may adversely affect Kaleyra’s results of operations.

Certain of our warrants are accounted for as a warrant liability and are recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of Kaleyra common stock.

Kaleyra has 373,692 warrants that were issued in private placements that occurred concurrently with its initial public offering (the “private warrants”). These private warrants and the shares of Kaleyra common stock issuable upon the exercise of the private warrants are exercisable for cash or on a cashless basis, at the holder’s option, and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the private warrants are held by someone other than the initial purchasers or their permitted transferees, the private warrants will be redeemable by the Company and exercisable by such holders on the same basis as the warrants included in the units sold in the Company’s initial public offering, in which case the 373,692 private warrants could be redeemed by the Company for $3,737. Under U.S. GAAP, Kaleyra is required to evaluate contingent exercise provisions of these warrants and then their settlement provisions to determine whether they should be accounted for as a warrant liability or as equity. Any settlement amount not equal to the difference between the fair value of a fixed number of Kaleyra’s equity shares and a fixed monetary amount precludes these warrants from being considered indexed to its own stock, and therefore, from being accounted for as equity. As a result of the provision that the private warrants, when held by someone other than the initial purchasers or their permitted transferees, will be redeemable by the Company, the requirements for accounting for these warrants as equity are not satisfied. Therefore, Kaleyra is required to account for these private warrants as a warrant liability and record (a) that liability at fair value, which was determined as the same as the fair value of the warrants included in the units sold in the Company’s initial public offering, and (b) any subsequent changes in fair value as of the end of each period for which earnings are reported. As the fair value of the warrants is not considered material to the historical consolidated financial statements, it was recorded in the condensed consolidated financial statements during the six months ended June 30, 2021. The impact of changes in fair value on earnings may have an adverse effect on the market price of Kaleyra common stock.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

47


 

Item 6. Exhibits

 

Exhibit

No.

  

Description

 

 

 

  31.1*

 

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

  31.2*

 

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

  32.1*

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

  32.2*

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS

 

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*

Filed herewith

 

48


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

KALEYRA, INC.

 

 

 

 

Dated: August 9, 2021

By:

  

/s/ Dario Calogero

 

Name:

 

Dario Calogero

 

Title:

 

Chief Executive Officer, and President

(Principal Executive Officer)

 

 

KALEYRA, INC.

 

 

 

 

Dated: August 9, 2021

By:

  

/s/ Giacomo Dall’Aglio

 

Name:

 

Giacomo Dall’Aglio

 

Title:

 

Executive Vice President and Chief Financial Officer

(Principal Financial and Accounting Officer)

 

49